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Introduction 
1.0 Introduction 
Analytical methods that employ antibodies or antigens as primary reagents, 
designated as immunoassays, are now indispensable in a large number of clinical, 
pharmaceutical and basic scientific investigations. The development of immunoassays 
during the past decades has revolutionized the determination of drugs, hormones and 
pathogens in clmical, agricultural and pharmaceutical samples as well as contaminants 
in the environment. Of the wide range of immunoassays available, enzyme based 
immunoassays are well suited for testing large number of samples, detection of very 
small amounts of pathogens and for rapid on site assays that require little expertise. 
Advantages offered by enzyme immunoassays include a high degree of sensitivity resulting 
from the inherent magnification of the enzyme substrate reaction v^thout the need for 
radioactivity. Immunoassays are often preferred mainly because of their remarkable 
specificity, simplicity, rapidity and relatively low cost. 
1.1 Immunohistochemistry 
The identification of tissue antigens using specific antigen-antibody interactions 
and subsequent microscopic visualization is known as immunohistochemistry or when 
dealing wdth intact cells, as immunocytochemistry. For the first time this technique was 
introduced as a fluorescence based method by Coons et al (1941) and Coons and 
Kaplan (1950). In 1967 immunoenzyme histochemistry was founded, introducing 
antibodies conjugated with the enzyme horseradish peroxidase (HRP). This enzyme 
was capable of generating an insoluble coloured reaction product suitable for light 
microscopic visualization (Nakane and Pierce, 1967; Nakane, 1968). HRP and alkaline 
phosphatase from calf intestine or Escherichia coli are the most frequently used 
enzymatic markers in immunohistochemistry (Avrameas, 1969a; Hanker e^o/., 1977; 
Mason et al., 1978; Li et al., 1984). Glucose oxidase from Aspergillus niger 
(Avrameas, 1969b; Clark era/., \9S2) and Escherichia coli P-galactosidase (Bondi 
et al., 1982; Portsman et al., 1985) are also employed but only rarely. 
Until 1980 the applicability of immunochemistry was still hampered by the 
availability of limited number of traditionally raised polyclonal antisera which while 
useful in majority of studies, suffered from the problem of heterogeneity and lack of 
absolute specificity. The introduction of hybridoma technology for the production of 
mouse or rat monoclonal antibodies (Kohler and Milstein, 1975) against a wide range 
of human cellular epitopes should be acknowledged as the first major breakthrough in 
the areaof immunohistochemistry. Since the early 1980s the number of applications of 
immvmohistochemistry has increased drastically, and the technique has established itself 
as an important medico-biological investigatory tool. 
1.2 Immunochemical techniques 
During the last two decades, strategies that improve the sensitivity/effectiveness 
of the histochemical staining techniques have attracted considerable attention. Detection, 
localization and quantitation of antigens/antibodies by immunoenzjmiatic techniques 
necessitates the use of enzyme-protein conjugates and for the preparation of such 
conjugates, a number of procedures using various crosslinking agents are available. 
Useful procedure for the covalent coupling of the marker enzyme to antibody with 
glutaraldehyde has been described (Avrameas, 1969b; Nakane, 1968). An alternative 
method of covalent coupling of the enzyme to antibodies was given by Temyck et al 
(1976) using p-benzoquinone, but the harsh reaction conditions during conjugation of 
enzyme to antibodies and the large size of the antibody-enzyme complex after 
glutaraldehyde conjugation were the major concerns. Sternberger et al (1970) 
circumvented the problem of conjugation of antibodies with enzyme by introduction of 
the non covalent immunological procedure of peroxidase anti-peroxidase (PAP) 
complex. This involved a bridging antibody ie (sheep anti-mouse immunoglobulin) which 
binds simultaneously to primary mouse monoclonal antibody and peroxidase anti-
peroxidase complex formed by two different mouse monoclonal antibodies (Fig 1.1 
PAP and APAAP complex). 
In an attempt to improve the sensitivity of tlie assays, the extremely high binding 
constants of biotin (a water soluble vitamin) for the egg yolk protein avidin was exploited. 
The dissociation constant (Kd) of the avidin-biotin complex is exceptionally high (10'^ 
M) as compared to a Kd of 10"* - lO''" M for antigen antibody complex and a Kd of 
10" -^10"' M for those of lectins with carbohydrates (Capra and Edmundsum, 1977). 
The high aflfmity of avidin-biotin has been used for bacteriophage inactivation (Beeker, 
1972), for gene and cellular mapping (Heggeness et al., 1977), for selective adsorption 
of cells (Jasiewicz et al, 1976) and for immobilization of macromolecules (Manning et 
al., 1977). Guedson et al (1979) described two procedures for employing avidin-
biotin interaction for linking enzymes to proteins. In the first procedure biotin labelled 
antibody (or antigen), biotin labelled enzyme and native unlabelled avidin were used 
(Fig 1.1 Avidin-biotin complex). The procedure was also referred as bridged avidin-
biotin (BRAB) technique. The second procedure involved the use of biotin labelled 
antibody or (antigen) and enzyme labelled avidin (Fig 1.1 biotin/enzyme avidin), and 
was given the name labelled avidin-biotin (LAB) technique. The effects of introducing 
biotin into antibody showed that even after extensive substitution of amino groups in 
antibody molecules by biotin, the antigen-binding capacity was not significantly modified 
(Green, 1963; Avrameas, 1969a). 
Another promising technique for improving the sensitivity/efficiency of 
immunoenzymatic histochemical detection system is the dextran polymer technology of 
DAKO A/S researchers (Bisgaard etal, 1993., Bisgaard and Pluzek, 1996). Both 
enzymatic tracers and antibodies are coupled to a large dextran polymer, ensuring a 
high enzyme tracer/antigen ratio. This technology is applied for primary antibodies 
resulting in a one step procedure (DAKO EPOSTM), as well as for secondary antibodies 
resulting in a two step staining procedure (DAKO EnVisionTM). These detection 
systems provide good staining intensity, circumvent possible problems with endogenous 
biotin (Sabattini et al., 1998; Vyberg and Nielson, 1998) and reduce the three-step 
_t *l* 
Direct Indirect Enzyme-anti-enzyme 
(PAP or APAAP) 
s^ M 
Biotin/enzyme - avidin Avidin - biotin complex 
A A . Y A « 
Primary Unlabelled Enzyme Anti-enzyme Enzyme 
Antibody secondaiy antibody linked 
antibody secondary 
antibody 
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Figure 1.1 Schematic representation of immunologic labeling methods. 
streptavidin-biotin method to a two-step (EnVisionTM) or even a one-step (EPOSTM) 
user friendly procedure. 
1.2.1 Enzyme amplification systems 
The recently introduced enzyme amplification methods show great promise in 
enhancing the enzyme immunoassay detection limits (Bates, 1987). One type of enzyme 
amplification method, the enzyme cascade (Blake et ai, 1984; Hall et ai, 1984; Harris, 
1984) involves the use of one enzyme to activate a second enzyme, that inturn can 
activate a third and so on, and the final enzyme in the cascade is used to generate a 
signal. Therefore a single Analyte Dependent Reporter Enzyme (ADRE) can result in 
multiple signal generating enzyme. Another type of enzyme amplification utilizes the 
ADRE to generate a product which modulates and is cycled by enzymes of a signal 
generating system. Every molecule of the product formed by ADRE is cycled by the 
signal generating enzyme to produce many molecules of the colored product (Johannsson 
etal., 1985, 1986; Self, 1985,1986). 
Another novel signal amplification system termed as Catalyzed Reporter 
Deposition (CARD) or biotin-tyramide amplification system was introduced by Bobrow 
etal (1989) for immunoenzymatic assays. The method involves ADRE to catalyze the 
deposition of additional reporter enzyme on to the solid phase of the assay. Fig 1.2 
demonstrate the method utilizing an HRP ADRE to catalyze the deposition of additional 
HRP and alkaline phosphatase with colorimetric detection. Signal amplification with 
HRP was observed with the addition of the biotinylated phenolic compound followed 
by streptavidin-HRP. Untill now the rather laborious biotin-tyramide amplification has 
not been considered as a routine applied detection system in immunoenzyme 
histochemistry. The above technique appears to be particularly usefial in improving the 
poor staining intensities observed with some primary antibodies, and multi target non 
radioactive in situ hybridization using a sequential double immunofluorescence method 
(Kersten er a/., 1995; Raap etal., 1995). 

Figure 1.2 A flow chart for the HRP mediated deposition of AP and HRP in a 
mouse IgG assay 
Coat solid phase with anti-mouse IgG 
Incubate with mouse IgG 
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(HRP) 
Streptavidin-AP 
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(HRP-AMP AP) 
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OPD 
(HRP-AMP HRP) 
1.2.2 Immunogold techniques 
This technique uses colloidal gold labelled antibodies initially developed for 
immunoeiectron microscopy (Faulk and Taylor, 1971). Colloidal gold labelled antibodies 
may be used both directly and indirectly for the location of antigens with light, 
transmission or scanning electron microscopy. The preparation of gold probes is a 
simple two step procedure involving first the generation of a colloidal gold solution 
containing particles of a narrow range of sizes from 5 to 40 nm. Then the primary or 
species specific antibody, or protein A, is adsorbed on to the surface of the gold 
particles, giving rise to immunogold or protein A gold probe respectively, which are 
stable for long durations. The basic technique involves incubating cryostat or fixed 
sections of specimen first with primary antibody and then with immunogold probe. The 
labelling is highly specific and lends itself to quantitate merely by permitting the counting 
of the number of probes present in a sample. Pereira et al (1994) and Li etal{\ 995) 
used antibodies labelled with colloidal gold to identify and localize epitopes on the 
virus particles captured on antibody coated electron microscopic grids. Protein A gold 
preparations have also been used to localize Cryptosporidium antigens in the tissue 
sections (Lumb er a/., 1989; McDonald era/., 1995). 
As the small gold particles are not visible with light microscopy, Holegate et al 
(1983) adopted the silver enhancement from Danscher (1981) for the first immuno 
gold/silver staining techniques on tissue specimens. The technique involves the 
localization of gold probes by a silver precipitation reaction making the particles visible 
as brown/black deposits with light microscopy. It can be used for the enhancement of 
ultra-small gold particles both in light and electron microscopy. A Special feature of 
the silver precipitate end product is the possibility of dark field epi-polarization 
microscopy (De Waele etal, 1988). The dark field option is believed to be one of the 
most sensitive/efficient immunohistochemical detection methods available. Furthermore, 
it formed the basis of a double staining method in combination with a fluorescent alkaline 
phosphatase detection technique (Vander Loos and Becker, 1994). 
1.2.3 Immunofluorescence 
Fluorescence Immunoassay (FIA) combines the specificity of antibodies with 
the sensitivity of fluorimetric assays, usually by using antibodies coupled to a fluorescent 
chromophore. The location of specific antigens in a tissue or cell preparation may be 
studied by staining with specific antibody conjugated to a fluorescent chromophore 
and illuminating with ultra violet light. Fluorecein emits green light and Rhodamine emits 
orange light, where as the weak natural fluorescence of some biological material occurs 
in the blue region of the spectrum. Seto et al (2001) developed a high sensitivity 
Bioluminescent Enzyme Immunoassay (BLEIA) for prostate specific antigen using 
biotinylated firefly luciferase labelled antibody. Immunoflourescence may be performed 
in a number of different ways, illustrated in Fig 1.3. Although clear and sharp localization 
of antigens with single and double immunofluorescence techniques is beyond dispute 
(Pryzwansky, 1982; Brandtzaege/a/., 1983, 1997; Brandtzaeg, 1998), but these 
techniques still suffer from well known drawbacks: quenching of fluorescence signal at 
excitation, fading of fluorescence signal upon exposure to room temperature or 
occurrence of auto fluorescence caused by formaldehyde fixation. (Mesa-tejada, 1977; 
Taylor, 1978,1980; Valnes and Brandtzaeg, 1982;NaiemeM/., 1982; Mason era/., 
1983). Despite many technical improvements in this regard, the stability of a fluorescence 
signal has not come even close to that of permanent enzymatic reaction product. 
Therefore, light microscopic immunohistochemical techniques using enzymatic 
chromogens are perferred. 
In medical biology, a new generation of improved fluorescent labels (fluorescein 
isothiocyanate, FITC) and dyes have been introduced mainly evolving with fluoresent 
activated cell sorter (FACS) techniques (Raap et al, 1995). Cryptosporidium oocytes 
in water samples were identified using this technique. The technique involved the 
separation of FITC - antibody conjugated cells from other components of suspension 
Figure 1.3 Diagrammatic representation of various fluorescence immunoassays. 
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in FACS. The suspension is passed through a laser beam and cells are separated on 
the basis offluorescence intensity (Vesey era/., 1990,1997). 
Particle Concentration Fluorescence Immunoassay (PCFIA) is a relatively new 
and rapid immunoassay technique with high sensitivity. PCFIA relies on the principle 
that the number of free particles coated with antigen decrease during agglutination and 
that the angle at which a beam of light is scattered is a function of particle size. Jolly et 
a/ (1984) exploited this technique for the detection of murine monoclonal antibodies to 
human IgG in hybridoma culture supematants. For the antibody detection, antigen 
bound to submicron polystyrene particles is bound to its specific antibody, which 
intum is reacted with flourescein labelled affinity purified goat anti mouse IgG. After 
completion of the reaction and solid phase separated the total particle bound flourescein 
is quantitated by front surface fluorimetry. Jolly ef a/ (1984) reported that the sensitivity 
of the technique for antibody detection is comparable to that of ELISA. 
Fluorometric determinations have come to be regarded as a highly sensitive 
detection systems superior both to radio isotopic and enzyme labelled immunoassays 
in recent years. However, conventional fluorometric assays are often limited by high 
back ground and non specific fluorescence emitted by non target compounds in complex 
mixtures. A successful altemative has recently been realized in time resolved fluorometry 
(Soukka et al., 2001), where the desired signal is distinguished from the interfering 
background by temporal resolution. Time resolution (measuring of the fluorescence 
intensity after a certain delay time has elapsed from the excitation pulse) technology is 
a strategy to avoid interference caused by short lived natural fluorescence of biological 
material. Lanthanide chelates europium (III), (Eu^*), samarium (III), (Sm^*), terbium 
(III), (Tb^ "^ ) and dysprosium (III), (Dy^ "^ ) are very effective labels in time resolved 
fluorometry that exhibit long emission duration and a reasonably high quantum yield. 
Butcher et al (2003) developed a competitive solid phase assay for the low 
molecular weight metal binding protein, metallothionein. The assay was based on the 
10 
Dissociation Enhanced Lanthanide Flouro-Immunoassay (DELFIA) detection of anti 
metallothionein antibody bound to solid phase metallothionein. The assay involves 
binding and exchange of different lanthanide chelates followed by fluorescent detection. 
1.2.4 Immunoblotting/dot immunobinding 
Much of the early quantitative and qualitative measurement of immunochemical 
reactions such as the percipitin reaction (Kabat and Mayer, 1961), radial 
immunodifiusion (Mancini et al., 1964), farr assay (Wold et al., 1968), light Scattering 
procedures (Gitlin and Edelhoch, 1951) were observed in solution. With the advent of 
ELISA (Engvall and Perlmann, 1971) increasing number of assays are solid phase 
based (Kemeny and chantler, 1988). 
In recent years solid phase immnoassay techniques have found wide application 
in basic research and clinical studies. The high sensitivity which can be obtained with 
labelled ligands, and the ease of separation of bound from unbound reagents make this 
type of inununoassay particularly attractive. More recently the development of methods 
for transferring proteins from the gel phase of electrophoresis to a solid phase for 
immuno reaction permitted the optimal combination of high resolution gel electrophoresis 
with the sensitivity and sunplicity of solid phase immunoassays. The first practical method 
for transfer of protein from gel electropherograms to a suitable solid phase was reported 
by Renart etal{\979), who introduced the transfer by diffusion to activated cellulose 
by covalent binding. Towbin et al (1979), described the transfer of proteins in an 
electric field and non covalent binding to nitrocellulose from polyacrylamide gels. This 
feature can also be used in immunoassay where the resolving power of electrophoresis 
is not needed. Thus antigens can be applied in the format of dots or spots (Glenney et 
al, 1980; Hawkes et al., 1982; Herbrink et al, 1982; Huet et al, 1982; Yen and 
Webster, 1982). This technique of dot immunobinding permits the use of any desired 
geometry, and has the advantages of permitting multiple simultaneous assays, high 
sensitivity and simple operation (Hawkes, 1982; Gordon etal., 1983). 
1.2.4.1 Immobilizing matrices in solid phase immunoassays 
Among the numerous immobilizing matrices available. Nitro-cellulose (NC) is 
the most widely used. It is produced by allowing thin films of nitric acid esterified 
cellulose, solublized in organic solvent mixture (ether alcohol or acetic acid acetone), 
to gel by the evaporation of the solvents. Meticulous regulation of the conditions 
(temperature, time) of the drying processes determine the porosity of the membrane 
(Gershoni and Palade, 1983). NC filters were originally described as surface filters for 
micro filtration. They were intended for sieving by particle size thus retaining bacteria 
on or near the surface of the filter matrix. However in the current use of surface filters 
for blotting, they serve as depth filters in which the micromolecules concerned are 
adsorbed throughout the filter matrix predominantly by chemical interactions rather 
than actual mechanical sieving (Presswood, 1981). Hydrophobic effects probably play 
a role in the interaction and indeed subsequent elution of the protein from the filter is 
facilitated by the non ionic detergents Triton X-100 (Schneider, 1980). Some proteins 
specially those of low molecular weights bind with low affinity to NC and may be lost 
during transfer or subsequent processing (Kakita et al., 1982). To prevent such losses, 
the transferred polypeptides can be crosslinked to the filter, thereby covalently stabilizing 
the protein pattern (Gershoni et al., 1982). As suggested by Burnette (1981) less 
porous matrix (0.2 instead of 0.45 um) may also prevent such losses. The presence of 
cellulose acetate in nitrocellulose membrane filters seems to reduce their capacities to 
bind protein (Towbin et al., 1979). Schaltman and Pongs (1980) reported the use of 
cellulose acetate filters for protein blotting. 
Other matrices used include Diazobenzyloxymethyl (DBM) modified cellulose 
paper (Alwine et al., 1979). Upon transfer to DBM paper, negatively charged proteins 
probably interact first electrostatically with the positively charged diazonium groups of 
the paper. This interaction is followed by a slow second step in which essentially 
irreversible covalent linkage via azo derivates is accomplished (Alwen et al., 1977). 
Hence stable transferred protein patterns are obtained (Renart, 1979). However there 
is a slight loss in resolution from gel to blot in this material due to its intrinsic coaiseness 
as compared to membrane filters (Bumette, 1981). Glycine commonly used in transfer 
buffers may interfere with DBM protein blotting (Kakita et al., 1982). Diazo paper, 
diazophenylthioether (DPT) paper has been found to be as efficient but more stable 
than DBM paper (Clarke/Of/., 1979; Reiser era/., 1981). Cellulose acetate activated 
with CNBr has also been used and offers much the same advantages as the DBM 
paper. 
Two other materials commercially available are Gene screen and Zeta bind (ZB). 
Zeta bind is a nylon matrix (a polyhexamethylene adipamine), referred to as nylon-66, 
modified by the introduction of numerous tertiary amino groups during its manufacture. 
Thus it offers not only the mechanical strength but also the potential of very significant 
electrostatic interactions between the filters and the polyanions. As a result ZB has 
higher capacity for proteins than NC (Gershoni and Palade, 1982). A drawback of ZB 
is the possibility of high non specific protein binding during subsequent overlay analysis. 
One common characteristic of nylon membranes are their high affinity for common 
anionic dyes as coomassie brilliant blue or amido black (Bittner et al., 1980). This 
characteristic interferes with subsequent staining of the filters, to the extent that no 
convenient technique for the staining of proteins to these matrices has yet been 
developed. But proteins on NC can be stained readily with amido black 1 OB (Towbin 
et al., 1979), coomassie brilliant blue (Bumette er a/., 1981), aniline blue black (Bowen 
et al., 1980), ponceau S (Muilerman, 1982), fast green (Reinhart, 1982), and toludine 
blue (Towbin e/a/., 1982). 
Several proteins bind tightly to NC and are not readily released. This makes it 
one of the most useful solid matrix for wide range of applications (Harlow and Lane, 
1988). It is commonly used in quantitative and qualitative dot assays both for antibodies 
and antigens. It is also the most commonly used solid phase matrix for immunoblotting. 
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Protein antigen immobilized to NC often make extremely good immunogens (Steinitz 
et al., 1991). The complex acts as an effective adjuvant by slowly releasing particulate 
antigen, thus continuously stimulating the immune system. 
1.2.4.2 Applications of immunoblotting and dot immunobinding 
Protein blotting has proved to be a highly versatile technique and finding increasing 
applications. Dot immunobinding is attractive for a variety of routine diagnostic 
applications because the procedures permits the performance of multiple of assays on 
on a single strip and detects antigens/antibodies with high sensitivity. Hawkes et al 
(1982) demonstrated the feasibility of serological screening with a variety of antigens 
from commercially available kits. 
DNA-protein and RNA-protein interactions have been analyzed by protein blots 
by Bowen et al (1980). Histone H2 associations with H3 and H4 have also been 
demonstrated (Bowen et al, 1980). Fernandez - Pol (1982) identified the receptor of 
the epidermal growth factor (EGF) by overlaying a transferred membrane pattern with 
the hormone. 
Muilerman et al (1982) demonstrated the detection of an inactive enzyme on a 
protein blot. Phosphodiesterase I was run on a SDS-polyacrylamide gel and the protein 
was blotted on to nitrocellulose filter, which was subsequently reacted with anti-
phosphodiesterase I. The filter was then incubated with the crude prepapartion containing 
active enzyme which bound (via unoccupied sites) to the antibody already bound to 
the inactivated subunit of the enzyme immobilized on the filter. The filter was then 
tested for enzyme activity to detect the immunocomplexes. Olmsted (1981) used blots 
to purify monospecific antibodies. Polypeptides resolved on SDS-polyacrylamide gels, 
were blotted on to Diazophenylthioether (DPT) paper and the filters were overlaid 
with serum containing polyclonal antibodies. The single band containing antigen-antibody 
complexes were excised from the filters and monospecific antibody was eluted from 
the excised strips by incubating them at low pH (Adair et al, 1982; Bell et al, 1982). 
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Hayman et al (1982) used protein blots to demonstrate specific whole cell-
polypeptide interactions. Human plasma was run on SDS-polyacrylamide gels and 
transferred to nitrocellulose. Once quenched, the filters were incubated with normal 
rat kidney cells which specifically bound to immobilized polypeptides presumably 
involved in cell attachment. The cells were stained with amido black lOB and were 
found to locate themselves at two discrete bands. 
Symington ef a/ (1981) and Erickson et al (1982) have found that transfer of 
'••C or ^ S^ labelled polypeptides from gel to filters increases the efficiency of polypeptide 
detection by autoradiography. Distance between the emitting radioisotope and the 
surface of the photographic emulsion is a critical parameter, determining the efficiency 
of autoradiography for low energy P-particles. Thus by transferring radioactively labelled 
proteins from relatively thick (~ 1 mm) wet gels to a thin (100-200 |im) dry membrane 
filter, greater sensitivity in autoradiography is achieved. 
Assays were further developed for total IgE and two allergens from dust mite 
and bee venom and showed that the system is specific for IgE and sufficiently sensitive 
for their determination in serum (Derrer et al., 1984). The assay was reproducible 
with coefficient of variation between 3 and 6 % and correlated well with commercial 
assays for total IgE and the allergen-specific IgE. Walsh et al (1984) developed a 
similar system for qualitative use with several allergens deposited on nitrocellulose discs. 
Autoimmunity profile for connective tissue diseases measures anti-DNA 
antibodies, rheumatoid factor and antibodies against sub cellular fractions of HeLa 
cells (Gordan and Rosenthal, 1984b). The assay correlated well with commercial test 
for rheumatoid and anti-nuclear factor and with clinical diagnosis. 
Pappas et al (1983) applied dot immunobinding to visceral leishmanias. They 
performed assays with serial dilutions of sera with single dots in micro-titre plate wells 
and showed that, in spite of cross- reactivity with African Trypanosomiaisis, Chagas 
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disease and Lupus Erythromatosis, the tests were diagnostically useful and lend 
themselves speciallj' well to field screening. They also found that far less antigen was 
required per test than in a comparable enzyme irmnunoassay. 
Dot immunobinding and inuniunoblotting were also used for detecting nanogram 
quantities of small peptides (angiotensin I, angiotensin II and met-enkephalin) on divinyl 
sulfone and gluteraldehyde activated nitrocellulose. Peptides were attached to the 
membrane by reaction of the amino group with the free carbonyl forming peptide bonds, 
analyzed with specific rabbit antibody against the peptide and visualized by HRP 
conjugated anti-rabbit antibody (Lauritzen etal., 1990). 
Kristoffersen et al (1994) used dot immimobinding assay to demonstrate and 
characterize the functional activity of soluble Fc gamma receptors (FcR). Samples 
containing soluble FcR were immobilized on a nitrocellulose membrane. Immune 
complexes of HRP and rabbit IgG antibodies to HRP were allowed to react with 
nitrocellulose bound FcR and the immune complexes were visualized by HRP developer. 
For detecting mite antigens in house dust sample, Mistrello et al (1998) developed 
a dot immunobinding assay, which uses a nitrocellulose dipstick spotted with specific 
anti-mite antibodies that act as a capture matrix. The same antibodies act as a detecting 
reagent when conjugated with colloidal dye particles and the test response is visible as 
a colored spot. Solid phase immunoassays are sensitive, specific £ind low cost diagnostic 
tests for detection of specific antigens in tears, urine and dermal fluid (Ngu et al, 
1998). 
Mangold etal{\ 999) detected the elevated levels of circulating antigen 85 by 
dot immunobinding assay in wild animals with tuberculosis. The assay also provides an 
important adjunct to intradermal skin testing for antemortem diagnosis of tuberculosis 
in non domestic species. 
For the rapid diagnosis of Tuberculosis Meningitis (TBM), Sumi et al (2000) 
developed a dot immunobinding assay to measure circulating anti mycobacterial antibody 
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in the cerebrospinal fluid (CSF). Specific CSF-IgG to Mycobacterium tuberculosis 
from TBM patient was isolated and coupled with activated CNBr Sepharose 4B. Using 
an immunosorbent affinity column, a 14 KDa antigen present in the culture filtrates of 
Mycobacterium tuberculosis was isolated and used in the dot immunobinding assay 
to quantitate specific antimycobacterial antibodies in CSF specimens. Siddiqui et al 
(2002) recently studied the selective binding of the melanoma cell TF- apoprotein to 
haemoglobin using dot immunobinding assay and western blotting. 
1.3 Human serum albumin 
Serum albumin belongs to a multigene family of proteins that includes 
a-fetoprotein (AFP) and human group- specific component (GC) or vitamin D binding 
protein. It is relatively large multi-domain protein which, as the major soluble protein 
constituents of the circulatory system, has many physiological fimctions. Serum albumin, 
also known as plasma albumin was recognized as a principal component of blood by 
Ancell(1839). 
Originally, the protein was referred to as "albumen" derived from the latin word 
albus meaning "white", after the white colour of flocculant precipitate produced by 
various proteins. Serum albumin is located in nearly every tissue and body secretions. 
About 40% of the total albumin is found in the circulatory plasma (Peters, 1970) where 
as of the remaining 60%, about half resides in viscera and half in muscle and skin 
(Rabilloud et al., 1988). Albumin also occurs in milk (Phillippy and Mac Carthy, 1979), 
amniotic fluid (Bala et al., 1987), semen (Blumsohn et al., 1991) and mammary cyst 
(Balbine^a/., 1991). 
Albumin concentration in plasma in an average person is about 35 - 50 g/1 which 
declines slightly with age (Cooper and Gardner, 1989) but is lower in newborns 
(Cartlidge and Ruter, 1986) and as low as 20g/l in premature infants (Reading et al., 
1990). Albumin is produced by the liver at the rate of 0.7mg/g liver per hour (Peters, 
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1985). About 4 - 5% of albumin is daily replaced by hepatic synthesis (Olufemi et ai, 
1990). Albumin concentration in plasma is maintained through transcriptional control 
of the albumin gene by the anabolic hormones-insulin and somatotrophin (Hudson et 
al, 1987). Albumin synthesis is also highly dependent upon the supply of dietary amino 
acids (Kaysen et al., 1989). 
1.3.1 Functions of albumin 
Albumin contributes to about 80% of colloid osmotic blood pressure 
(Lundsgaard, 1986) and 100% of the protein effect in the acid base balance of plasma 
(Figge etal., 1991). It acts as a carrier for long chain fatty acids (Brodersen et al., 
1991; Cistola and Small, 1991), their acyl coenzyme A esters (Richard et al., 1990) 
and mono acyl phospholipids (Robenson et al., 1989) and affects the activity of lipase, 
esterases (Posner et al., 1987) and carnitine acyl transferase (Richards et al., 1991). 
Albumin binds polyunsaturated fatty acids (Anel et al, 1989) and influences the stability 
(Haeggstrom et al., 1983), biosynthesis (Heinsohn et al., 1987) and transformations 
of prostaglandins (Dieter et ah, 1990). It binds weekly to cholesterol (Deliconstantinos 
et al., 1986), bile acids (Malavolti et al., 1989), corticoid hormones (Watanabe et 
al, 1991; Mendel etal., 1990) sex hormones (Pardridge, 1988) and is involved in 
transport of thyroid hormones (Mendel et al., 1990). Albumin also helps in the transport 
of pyridoxal phosphate (Fondae^a/., 1991), cysteinand glutathione (Joshi etal, 1987) 
by forming a covalent bond with these ligands. 
Albumin is responsible for the transport and store housing of many therapeutic 
drugs in the blood stream (Lindup, 1987). Albumin is an important constituent of tissue 
culture media (Barnes and Sato, 1980) and serves as a medium to support the growth 
of bacteria, fungi and yeast (Callister et al., 1990; Morrill et al., 1990). 
Albumin because of its low cost and availability in pure form has been used as a 
standard for assays of total protein by the method of Lowry etal {\9S\), Biuret (Gomall 
et al, 1949 and coomassie blue (Bradford, 1976) procedures for many decades. It is 
also used in the standardization of other types of analyses and as reference for gel 
electrophoresis, diffusion techniques, sedimentation in ultracentrifugation and in bilirubin 
determination (Szabolcs and Francia, 1989). Fructosamine - albumin serves to 
standardize protein bound fructose assays (Podzoiski and Wells, 1989). 
1.4 Immunoaffinity based immobilization 
Inmiimoaffmity chromatography is a powerful technique for the isolation of the 
individual protein from complex mixtures. The procedure involves the attachment of 
the antibodies to solid supports like Agarose, Sepharose or synthetic organic and 
inorganic porous bead matrices (Grormian and Wilchek, 1987). 
Immobilization involves the reaction of the surface nucleophilic group (mostly 
primary amines) of the antibody with polysaccharide support activated by CNBr 
(Coding, 1983) epoxy activation using epichlorohydrin (Pepper, 1992) or bisoxiranes 
(Sunderberg and Porath, 1974). Most of these immobilization procedures result in 
random immobilization of the antibody molecule on the support. Immobilization of the 
antibody on an immobilized protein A column however, leads to the favourably oriented 
attachment of the antibody (Gersten and Marchalonis, 1978; Solomon et al, 1986). 
Oriented immobilization of antibodies on support via their oligossacharide chains which 
are mainly located in the Fc region of the molecdule has been reported by Quash et al 
(1978) and Fleminger et a/ (1990). 
Immobilization of enzymes using anti-enzyme antibodies has long been studied 
and reviewed (Shami et al., 1989) and is a versatile technique as specific antibodies 
can be raised against any enzyme in suitable animals (Ehle and Horn, 1990). A variety 
of approaches have been adopted for the immobilization of enzymes with the help of 
antibodies. The simplest being the formation of enzyme- antibody complex for which 
neither pure antibody nor pure enzyme is a prerequisite. Bumette and Schmidt (1921) 
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demonstrated for the first time that insoluble immuno-complex of catalase and anti 
catalase antibodies retained complete enzyme activity and have marked stability against 
various denaturing factors (Shami etai, 1991; Jafri and Saleemuddin, 1993). 
A considerable number of enzymes have been immobilized on various immuno-
adsorbents prepared using polyclonal or monoclonal antibodies. It was observed that 
binding of enzymes on immuno-adsorbents prepared using polyclonal antibodies is 
relatively strong due to the binding of antigen to more than one kind of antibody (Hansen 
and Beavo, 1982; Ernst-Carbrera and Wilchek, 1988). Monoclonal antibodies also 
appears to have shorter half lives and are more labile compared to polyclonal antibodies 
(Coding, 1985; de-Alwis and Wilson, 1989). Schramm and Pack (1992) studied antigen 
antibody complex formation using monoclonal antibody for its possible use in optimising 
enzyme immunoassays. 
Procedures that result in the binding of large quantities of enzymes on supports 
are advantageous in nearly all applications requiring immobilized enzymes and such 
strategies are particularly helpful in the construction of enzyme based biosensors that 
necessitate the fixation of large amount of enzymes on a relatively small area for maximum 
sensitivity (Alvarez-Kaza and Bilitewski, 1993; Vanderberge/a/., 1994). 
Farooqi etal(l999) described a procedure for the high yield immobilization of 
enzymes with the help of specific anti-enzyme antibodies. They demonstrated that 
immobilization of glucose oxidase and horseradish peroxidase was achieved by binding 
the enzymes to a Sepharose matrix coupled with IgG isolated from anti-glucose oxidase 
and anti-horse radish peroxidase sera, erspectively. The procedure further followed 
alternate incubations with the IgG and the enzyme to assemble layers of enzyme and 
antibody on the support. The immunoaffinity layered preparation obtained after six 
binding cycles contained 25 times more immobilized enzyme over that bound initially. 
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1.5 Immunoglobulins 
Immunoglobulins (Ig) are soluble glycoproteins that circulate freely in blood and 
exhibit properties that contribute specially to immunity and protection against foreign 
material. Antibodies which are present in gamma globulin fraction of serum are slowest 
migrating proteins in an electrophoretic field (Porter, 1959; Kabat et al, 1961)). 
Immunoglobulins possess two distinct type of polypeptide chains linked by both 
covalent and non covalent bonds (Milstein and Pink, 1970). The smaller light chain 
(MW 25,000) is characteristic of this whole group of proteins and is of two types -
kappa (k) and lambda (X|). The larger heavy chain (MW 50,000 - 77,000) is specific 
for each class. Based on antigenic as well as structural properties of the heavy chain, 
the immimoglobulins are classified as IgG, IgA, IgM, IgD, IgE, the heavy chains of 
each class designated by greek letters y, 0(|, M, 5 and e respectively. 
Aminoacid sequencing of immunoglobulin heavy and light chains showed that 
both chains contain several homologous units of about 110 amino acid residues containing 
interchain disulphide bonds approximately 60 residues apart (Kabat and Wu, 1970). 
The first or the N - terminal domain on both light and heavy chain is highly variable in 
terms of amino acid sequence and is designated as V^^ or V^^ accordingly. The structural 
genes for Ig variable region exist in the genome as a multigene system (Hood and 
Talmage, 1970). The subsequent domains on both chains are much more conserved in 
amino acid sequence and are designated C^^ or C^l, C^2, and C^3. Each domain has 
evolved to fulfil a specific function. The major function of V^^ and V^ domain is to 
provide the antigen binding site. A region between Cj^ l and C^2 domains containing 
the interchain disulphide bonds is known as the hinge region (Stanworth and Turner, 
1986). This region which is a segment of the heavy chain is unique for each class and 
subclass of immunoglobulins. Flexibility in this area permits the antigen binding sites to 
operate independently. 
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1.5.1 Immunoglobulin G 
IgG is the predominant immunoglobulin in blood, lymph, cerebrospinal fluid and 
peritoneal fluid. The four chain structure of IgG was proposed by Porter (1959) and 
its complete sequence elucidated by Edelman, (1969). They are multimeric proteins 
with a molecular weight of 150KDa corresponding to a sedimentation coefficient of 
7S. IgG is made up of two heavy gamma (y) chains and two light chains, either kappa 
(k) or lambda (k) linked together by disulphide bonds (Fig 1.4). Based on minor 
differences in the aminoacid sequence of heavy chains there are four IgG subclass in 
humans namely IgGl, IgG2, IgG3 and IgG4. Mice also synthesize four subclasses of 
IgG designated as IgGl, IgG2a, IgG2b and IgG3 (Edelman et al., 1970). 
The constant region of the gamma chain is constructed from three homologous 
units designated C^ l^, C^, and C^ S^ and contains a stretch of aminoacid residues 
between C j^l and C^, in the hinge region which shows no homology with any of the 
homologous units. This region is rich in proline residues and also contains the cysteine 
residues that link the two heavy chains together (Edelman et al, 1970). This region 
acts as a susceptible site for proteolytic cleavage, as the amino acid residues in this 
region are exposed to the surrounding medium. 
1.6 Porcine pepsin 
Aspartic proteinases (EC 3.4.23.X) are a group of proteolytic enzyme which 
operate at acidic pH and possesses remarkable homology in their tertiary structures 
(Pitts et al., 1992). X-ray crystallographic data reveal that this group of enzymes share 
a bilobal symmetry, with the two structural domains separated by a hinged substrate 
binding cleft. Two active site aspartic residues occupy the cleft to which admittance is 
restricted by a hinged flexible flap region (Suzuki et al, 1989). Although high in structural 
homology, these enzyme differ markedly in their catalytic functions, indicating that their 
activity is the result of subtle differences in protein structure. 
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Figure 1.4 Three dimensional structure of immunoglobulin molecule (a) and pictorial 
representation of IgG (b). 
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Pepsin is the principal proteolytic enzyme of vertebrate gastric juice and the first 
enzyme to be studied and the second to the crystallized (Northrop, 1930). Consequently 
pepsin is the best understood of this family of proteases and has been used as a model 
to study related enzymes (Lin et al, 1983; Abad Zapatero et al., 1990). 
1.7 Procedures for producing F(ab)'j 
F(ab)'J are the bivalent antibody fragments obtained by cleaving the antibody 
below the hinge region. The use of F(ab)'j fragments may in some immunological tests 
systems is advantageous over the use of intact IgG mainly because non-specific binding 
through the Fc part can be avoided. The standard procedure of F(ab)'^ isolation involves 
IgG purification from whole serum by triple salt precipitation using sodium sulphate 
(Kekwick, 1940), followed by chromatography on DEAE cellulose (Levy and Sober, 
1960). Purified IgG digested with pepsin (Nisonoff e^  al., 1960) showed the formation 
of a single large fragment F(ab)'j along with a heterogeneous assortment of small 
peptides (Fig 1.5). F(ab)'2 was isolated by gel filtration through Sephadex G -150 
(Jaquet and Cebra, 1965). 
Madson and Rhodkey (1976) devised an alternative method to isolate functionally 
active antibody F(ab)'j fragments from small amounts of serum. The fragments were 
produced by digesting ammonium sulphate saturated serum with pepsin, and F(ab)'j 
were then isolated through gel filtration chromatography. Total serum IgG F(ab)'j 
recovered was 90% using the technique, as compared with the usual 20 - 25 % recovery 
using standard isolation procedures. Poulsen and Hjort (1980) devised another method 
for the preparation of F(ab)'j by pepsin digestion of whole serum proteins. They also 
showed that most of the serum proteins could be degraded to small peptides which 
were removed by dialysis. 
Various methods for improved pepsinolysis of different immunoglobulins and 
immunoglobulin G subclasses were also described. Lamoyi and Nisonoff (1983) 
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Figure 1.5 Schematic representation of cleavage of IgG by papain and pepsin 
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investigated the effect of peptic digestion on mouse monoclonal immunoglobulin of 
each subclass of IgG. FCab)'^  fragments were obtained in good yield from IgGl, 
IgG2, and IgG3. The relative rates of digestion were IgG3>IgG2>IgGl. 
For human IgG there have been a number of investigations of proteolysis by 
papain, pepsin and trypsin. The fragments produced thereby including Fc, F(ab) and 
F(ab)'2 have been well characterized (Bennich and Johnsson, 1971). Haba and Nisonoff 
(1990), studied the conditions for the preparation of F(ab) and F(ab)'2 fragments of 
mouse IgE by proteolytic digestion. Pepsin and trypsin, each produced F(ab)'j 
fragments with molecular weight of 130 KDa which yielded Fab fragment on further 
digestion. The best yield of F(ab) were obtained with papain. Results of digestion 
were in order: Pepsin > Trypsin > papain. 
The most important subclass of mouse immunoglobulin IgGl is quite resistant to 
pepsin cleavage (Gorini et al., 1969; Lamoyi and Nisonoff, 1983; Mariani et al., 
1991; Andrew and Titus, 1997). Wilson et al (2002) devised an improved method for 
pepsinolysis of mouse IgGl molecules to F(ab)'j fi-agments. They reported that IgG 
molecules can be rendered pepsin sensitive by treatment with peptide N-glycosidase 
F (PNFase), an enzyme that removes N linked oligosaccharides from proteins. 
F(ab)'J or F(ab) are widely used for the treatment of snake envenoming (Karlson-
Stiber, 1994; Jones et al., 1999; Theakston et al., 2000). Such products should 
comprise only highly pure immunoglobulin fragments since Fc or other contaminating 
protein firagments or their aggregates may lead to side effects (Hristova, 1968b; Bleeker 
etal., 1987; 1988; 2000). Jones and Landon (2002) gave a novel process for enhanced 
pepsin digestion and F(ab)'^ fragment production in high yield from serum. They showed 
that trypsin was effective at digesting purified IgG but unsuitable for the direct digestion 
of serum while Pepsin was highly effective at digesting all unwanted serum proteins to 
low molecular weight fragments leaving the 100KDaF(ab)'2 intact. Low molecular 
weight fragments were dialyzed out through a 30 KDa cut piperazine membrane, while 
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pepsin and high molecular weights peptides were removed using anion exchange 
coloumn. The purity of F(ab)'^ was over 96% and yield was also impressive. 
F(ab)'J fragments were also purified by hydrophobic interaction high performance 
liquid chromatography (HPLC) using TSK gel Phenyl - 5PW from pepsin digest of 
mouse monoclonal antibodies IgG (Morimoto, 1992). Digests were applied to the gel 
equilibrated with phosphate buffered saline containing one molar ammonium sulphate. 
F(ab)'j fragments were adsorbed onto the gel and eluted by reducing the ammonium 
sulphate concentration to zero molar. This method is useftil for large scale production 
of F(ab)'j. Hydrophobic interaction HPLC technique was also used to purify F(ab)'2 
from mouse immunoglobulin M (Inouye and Morimoto, 1993). The F(ab)'j derived 
from IgM lost the compliment binding activity and the sugar content was also reduced. 
Its binding to non specific proteins tumed to be negligible suggesting that the fragments 
were usefiil for immunological application. Pascual and Clem (1992) gave an effective 
procedure for mouse IgM F(ab)'j production by digesting murine IgM antibodies with 
pepsin at low temperature. They reported that digestion performed at 4°C of 
immunoglobulin M yields higher ratio of F(ab)'j fragments than those obtained by 
digestion performed at 37°C. 
Akita and Nakai (1993), reported the formation of F(ab)'j from chicken egg 
yolk immunoglobulin Y (IgY). They reported that optimum yield of F(ab)'2 was obtained 
after peptic digestion of IgY at pH 4.2 for nine hours at lowNaCl concentration. By 
combination of ultra filtration and anion exchange, pure F(ab)\ fragments were easily 
obtained in the eluent, as the contaminants bind to the anion exchange column. With 
this approach large amount of F(ab)'j were purified using a small column. 
F(ab)'j fragments were also obtained by cleaving IgG with immobilized pepsin 
preparation (Tomono et al., 1981). Pepsin was immobilized onto glutaraldehyde 
activated AH sepharose 4B under acidic conditions and was found to retain 30% 
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activity towards IgG. The immobilized pepsin thus prepared was efficiently used for 
the limited cleavage of IgG and gel filtration yielded very pure F(ab)'2. 
Benanchi et al (1988) described a two step procedure for purifying F(ab)'^ from 
horse immunoglobulins. In the first step, the horse plasma was diluted with ammonium 
sulphate and digested with pepsin. In the second step, the perviously dialyzed solution 
was chromatographed on DEAE cellulose covalently linked to a synthetic vinyl polymer. 
With this assembly, chromatography can be performed at high flow rate with out the 
problems related to the use of large columns. The yield and purity of F(ab)'jObtained 
was satisfactory. 
For the purification of F(ab) fragment papain attached to solid phase CH-
Sepharose 4B was used to digest rabbit IgG. Protein A-Sepharose CL-4B was used 
to remove undigested IgG and Fc fragment. The yield reported was 75% (Coulter and 
Harris, 1983). 
Lihme etal (199 \) reported the binding of almost all serum proteins at high 
concentration of ammonium sulphate on affinity matrix prepared by coupling 
mercaptoethanol to divinysulfone activated agarose (T-gel). They showed good 
recovery of proteins with an excellent separation by gradually lowering the concentration 
of salt in the washing buffer. Thiophilic adsorption chromatography (TAG) was also 
employed for purification and separation of mouse F(ab) firagment fi-om IgG, monoclonal 
antibodies (Yurov et al., 1994). TAG was performed using stepwise elution with 
decreasing concentrations of ammonium sulphate. Most contaminating proteins did not 
react with the thiophilic adsorbent and chromatography efficiently resolved the F(ab) 
and Fc fragments. TAG was also employed for the purification of a recombinant F(ab) 
fragment of antibody IN-1 from the periplasmic protein fraction of Escherichia coli 
(Fiedler eM/., 1999). 
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1.8 Use of IMAC for purifications of immunoglobulis 
Immobilized Metal ion Affinity Chromatography (IMAC) is a highly versatile 
separation technique based on interfacial interactions between metal ions immobilized 
on a solid support which is usually a hydrophilic cross-linked polymer and basic group 
on proteins mainly histidine residues (Fig 1.6). Terminal amino group, tryptophan, 
tyrosine, phenylalanine, and cystein residues (Table 1.1) may also be involved in the 
binding (Martin, 1979; Sulkowaski, 1985). This concept of using chelated metal for 
the selective adsorption of protein was first introduced by Porath (1975) and the 
technique renamed as IMAC by Porath and Olin (1983). 
Traditional affmity chromatographic methods for immunoglobulins purifications 
such as protein A (Fuglistaller, 1989), protein G (Blank and Vetterlein, 1990), k-specific 
affinity (Bazin and Cormont, 1975) or anti-Ig specific immuno-adsorbents oflen requires 
elution at low pH or with detergents or chaotropic salts. Such elution conditions are 
often damaging to the antibody being purified. Further more, chromatographic methods 
selective for the N-terminus of IgG will co-purify antibody and degradation products 
such as Fab or F(ab)'j. In contrast to aflSnity chromatography, the metal chelate technique 
does not damage the antibody or elute metal fi"om the column. The potential use of this 
technique for the isolation of human and murine IgG, has been shown by Hale and 
Biedler (1994). The near complete removal of albimiin makes IMAC and alternative 
to salt precipitation of antibody from ascetic fluids. Further studies by Hale (1995) 
showed that the metal chelate column is selective for the Fc portion of the 
immunoglobulin. Data base analysis suggest that histidine rich region of C^3 domain is 
the specific site of interaction and is well conserved among several immunoglobulin 
classes. 
Recent application of IMAC range from purification of recombinant growth 
hormone (Maisano and Testpro, 1989) and tissue plasminogen activator (Furlong and 
Thompson, 1988) to purification of wheat amylases, glycophorins and immunoglobulins 
and their subclasses from ascetic fluids (Fuglistaller, 1989). 
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Figure 1.6 A diagrammatic representation of the principle of IMAC. 
30 
M 
A 
T 
R 
I 
X 
- A - E 
Me 
= ^ 
M 
A 
T 
R 
I 
X 
- A - B 
His-protein 
EDTA M 
A 
T 
R 
I 
X 
- A - B 
A 
B 
Me 
L1&L2 
Linkage Group 
Chelating Group 
Metal ion 
Solvent or buffer molecule 
TABLE 1.1 
Mechanisms of protein binding to Cu(II), Ni(II) and Zn(II) IDA: Relative contributions 
to apparent metal affinity from aminoacid side chains and N-terminus 
Functional group side 
chains 
His 
Cys 
Asp,Glu 
Lys, Arg 
Trp, Tyr, Phe 
N - terminus 
Contribution 
++++ 
++++* 
-
+ 
+ 
++ 
Mechanism 
Direct 
Direct 
Indirect 
Indirect** 
Indirect 
Direct 
* An accessible cycteine will bind only in its reduced form. Metals catalyze the 
oxidation of cystein 
** Becomes direct at high pH 
Ref : Sulkowski (1985), TIBTECH :3,pp4. 
1,9 Objective of the work 
Enzyme coupled immunoassays are widely used in revealing antigen-antibody 
interactions on solid matrices. Interesting variations involving the use of new and more 
stable enzymes, chromogens and strategies like use of biotinylated antibodies and avidin 
conjugated enzymes have proved remarkably effective in improving the sensitivity of 
the immunoassays. The object of the work was to investigate procedures for improving 
the sensitivity of the dot blot, westem blot and ELISA analysis of antigens using multiple 
incubation strategy that assembles large amount of the secondary antibody-enzyme 
conjugate in quantities proportional to the amount of antigen present on nitrocellulose 
strips or in ELISA plates. 
Efforts have also been made to develop a simple and rapid procedure for the 
isolation of FCab)'^  fragments from intact IgG. For this purpose the ability of Cu '^^ -IDA 
Sepharose to bind to IgG, Fc fragment but not to F(ab)'2 was made use of. A preparation 
of pepsin with attached additional histidyl group was used for the cleavage of IgG, 
since it could be quantitatively removed from the reaction mixture inview of its affinity 
for Cu^*-IDA Sepharose at neutral pH. 
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2.0 Materials 
Chemicals and reagents used for the present studies were obtained from the sources 
as indicated below. Glass distilled water was used in all the experiments. 
B.D.H Poole, England 
B.D.H, India 
Difco Laboratories Detroit, USA 
E.Merck, India 
Genei Pvt Ltd, Bangalore 
Merck-Schereherdt, Germany 
Sigma Cemical Co, USA 
Qualigen's Research Laboratories 
Bromophenol Blue 
Copper sulphate, hydrochloric acid, 
trichloroacetic acid 
Freund's complete adjuvant, Freund's 
incomplete adjuvant 
Ammonium sulphate, glycine, methanol, 
sodium hydroxide, sodium potassium 
tartrate 
Molecular weight markers, goat anti-
rabbit-HRP conjugate 
(3-mercaptoethanol 
Nitrocellulose membrane, pepsin, 
sepharose 4B, Comassie brilliant blue 
R- 250, sodium dodecyl sulphate, tris 
(hydroxymethyl amino-methane), 
hemoglobin, HS A 
Acetic acid, di-sodium hydrogen 
phosphate, glycerol, isopropanol, di-
hydrogen sodium phosphate, sulphuric 
acid, sodium chloride, sodium bi 
carbonate, zinc chloride, nickel chloride, 
cobalt chloride, ferric chloride, copper 
Sisco Research laboratories, India 
Koch-Light, England 
Pharmacia Fine Chemicals, Sweden 
Hi-Media, hidia 
Greiner-Labor-Technik, Germany 
chloride, hydrogen peroxide, ammonium 
sulphate, silver nitrate, potassium 
dichromate, tween - 20. 
N,N'-methylene bisacrylamide, 
acrylamide, ammonium persulphate, 
bovine serum albumin, cyanogen 
bromide, folin's ciocalteu's phenol 
reagent, sucrose, di-ethyl amino ethyl 
(DEAE) cellulose, ethylene diamine 
tetraacetic acid (EDTA). 
Glutaraldehyde 
Sepharose fast flow (IDA) 
Sodium azide 
Ninety six welled microtitre plate. 
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3.0 Methods 
3.1 Immunological procedures 
3.1.1 Preparation of the antigen 
For the immunization of rabbits, the antigen (300|ag HSA/0.5ml in 50 mM sodium 
phosphate buffer, pH 7.4) was mixed with equal volume of Freund's complete adjuvant 
in the ratio of 1:1 .The antigen for booster doses was prepared by mixing solution of 
HSA (150^g/0.5ml) with equal volume of Freund's incomplete adjuvant. The oil buffer 
mixture was thoroughly emulsified using a 21 gauge syringe. 
3.1.2 Immunization of rabbits 
Healthy albino rabbits weighing between 2 - 3 Kg were used for immunization. 
The rabbits were bled prior to immunization and the sera obtained served as control. 
Rabbits were injected subcutaneously with 1.0 ml of the HSA antigen and were rested 
for fifteen days. Booster doses were subsequently given weekly for four weeks. After 
resting the animal for a week, blood was collected through posterior ear vein. The 
blood was allowed to coagulate at 22°C for three hours, centrifuged to collect antiserum 
which was then decomplemented at ST^ C for 30 minutes and stored at -20°C in small 
aliquots. 
3.1.3 Immunodiffusion 
Immunodiffusion was performed essentially by the method of Ouchterlony (1962). 
One percent molten agarose in normal saline containing 0.2% sodium azide was poured 
on glass plates and allowed to solidify at room temperature. Required number of wells 
were cut and the slides were stored at 4°C. Five to ten microliters of suitably diluted 
antiserum and required amount of antigen prepared in normal saline were added in the 
wells. The reaction was allowed to proceed for 12 - 24 hours in a moist chamber at 
room temperature. The Petri-plates were immersed in normal saline to remove non 
specific precipitin lines if any. 
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3.1.4 Isolation and purification of immunoglobulin G from the antiserum 
Rabbit IgG was isolated by a slight modification of the method of Fahey and 
Terry (1979). Fifty ml of antiserum was mixed with equal volume of 20 mM sodium 
phosphate buffer, pH 7.2 and 11.4 gm of solid ammonium sulphate added. The mixture 
was stirred to dissolve ammonium sulphate and to make it 20% saturated. After 6 
hours the sample was centrifuged at 2,000g for 20 minutes and the supernatant was 
made 40% saturated with respect to ammonium sulphate by adding additional 12.3gm 
of the solid. Precipitation was allowed to proceed for 12 hours at 4°C. The precipitate 
obtained was collected by centrifugation at 2,000g for 20 minutes. Most of the gamma 
globulin were present only in the 20 - 40 % pellet which was dissolved in minimum 
volume of 20mM sodium phosphate buffer, pH 7.2 and extensively dialyzed against 
the same buffer with frequent changes and stored at 4°C. 
3.1.5 Ion exchange chromatography 
Ten grams of DEAE cellulose was suspended in 0.5 N HCl for one hour and 
washed in a Buchner funnel with distilled water till the filtrate had neutral pH. The 
exchanger was then treated with 0.5 N NaOH for one hour and again washed with 
distilled water till the pH of the filtrate was neutral. The DEAE cellulose was then 
resuspended in 20 mM sodium phosphate buffer, pH 7.2 to obtain a homogeneous 
slurry. Fine particles were removed by decantation and the slurry poured in a clean 
vertically mounted column (1.8 cm X 10cm). The flow rate of the column was gradually 
increased to 30ml/hr. Buffer was carefully removed from the surface and the 20 - 40 % 
ammonium sulphate fraction was applied. Three ml fractions were collected after washing 
the column with one bed volume and analyzed for the protein content. The homogeneit}' 
of purified protein was assessed by SDS-PAGE. 
3.1.6 Preparation of F(ab) monomer 
Purified IgG (1 Omg) was dialyzed against 0.1 M sodium phosphate buffer, pH 
7.0. Cystein HCl (Img/lOmg IgG), EDTA (O.Smg/lOmg IgG) and papain (1 .Omg/ 
lOOmg IgG) were added to dialyzed IgG and the mixture incubated for four hours at 
37°C. The digest was frozen to inhibit further digestion and was later dialyzed against 
0.1 M sodium phosphate buffer, pH 8.0 overnight at 4°C. DEAE cellulose was 
regenerated as detailed above and equilibrated with 0.1 M sodium phosphate buffer 
pH 8.0. The dialyzed digest was applied to the coliimn and a gradient of phosphate 
buffer was run from 0.1 to 0.3 M at pH 8.0. The first peak was F(ab) monomer while 
the second peak was predominantly Fc (Catty and Raykundalia, 1988) 
3.1.7 Formation of F(ab)\ 
IgG was digested with pepsin in order to obtain the F(ab)'2 fi^agments as described 
by Nisonoff et al (1960). Pepsin (2mg) was dissolved in one ml 0.2 M sodium acetate 
buffer, pH 4.5. IgG dialyzed against the same buffer was mixed with the enzyme solution 
to give an enzyme: IgG ratio of 1: 100 and the mixture was incubated at 37°C for 24 
hours. The reaction was terminated by the addition of solid tris salt that increased the 
pH of the reaction mixture to 8.0. The F(ab)', fragments were then characterized by 
SDS-PAGE. 
3.1.8 Purification of specific IgG 
HSA was coupled to CNBr activated sepharose 4B by the procedure of Porath 
et a/ (1975). The preparation obtained thus contained 5.0 mg of HSA per 1.0 gm of ' 
gel. A column of activated sepharose 4B was packed in a 50 ml glass syringe by 
carefully adjusting the flow rate. The affinity purification of specific IgG was achieved 
by coupling HSA to Sepharose 4B following the procedure of Stults etal (\9S9) with 
some modifications. Briefly the HSA specific antiserum was allowed to bind to the 
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HSA 4B affinity column. The column was washed thoroughly with 0.1 M tris HCl, pH 
8.9 containing 2.5 M NaCl in order to remove any unbound or non specifically associated 
protein. The bound IgG were eluted with 0.1 M glycine-HCl buffer, pH 3.5 and the 
eluate immediately neutralized with this buffer. 
3.1.9 ELISA 
Buffers and substrates:- The following buffers and substrates was used 
1. Tris Buffered Saline (TBS):- 20 mM tris, 150 mM sodium chloride, pH 7.4 
2. Tris Buffered Saline Tween-20 (TBS-T):- 20 mM tris, 14.3 mM NaCl, 200 mg 
KCl and 500 |al tween-20 were dissolved in 800 ml distilled water and pH was 
adjusted to 7.4 with IN HCl. The volume was made to one litre. 
3. Bicarbonate buffer:- 50 mM, pH 9.5 contained 0.02% sodium azide as 
preservative 
4. Substrate used is Tetramethylbenzidine/H202 (Commercial preparation diluted 
1:4). 
Direct ELISA 
The titre/generation of human serum specific antibodies was measured in the 
sera of HSA immunized rabbits by the ELISA (Autsuka, 1979). Ninty six welled 
microtitre plates (Greiner Labor-technik, France) were coated with 100 |il of HSA at 
a concentration of 5 mg/ml in 0.05 M carbonate bicarbonate buffer, pH 9.6. the plates 
were incubated for 2 hours at room temperature and then overnight at 4°C. The antigen 
coated wells were washed three times with TBS-T buffer in order to remove unbound 
antigens. Unoccupied sites in the wells were blocked with 150 ml of 1.5% (w/v) 
skimmed milk in TBS for three hours at room temperature. The plates were washed 
with TBS-T and serially diluted antiserum (100 |j,l/well) in TBS to be tested was added 
to each well (1:1000 ^1:102400) and incubated for 2 hours at room temperature. 
Bound antibodies were assayed using the commercial secondary antibody-HRP 
conjugate at a 1:3000 dilution. After the usual washing steps the peroxidase reaction 
was initiated by the addition of the substrate tetramethylbenzidine/H^O,, arrested by 
the addition of 4.0 N H,SO. and absorbance of each well was monitored at 450 nm in 
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an ELISA reader. Each sample was coated in duplicate and results were expressed as 
mean of (A test - A control). A is the absorbance at 450 nm. 
3.1.10 Immunoaffinity layering in ELISA 
One hundred microliters of serially diluted HSA(l|ig to O.OOlpg) in 0.05 M 
sodium bicarbonate buffer pH 9.6 were coated in 96 welled microtitre plates for two 
hours at room temperature. The antigen coated wells were washed 3 times with TBS-
T to remove unbound antigens. Unoccupied sites were blocked with 150 |j|l of 1.5 % 
(w/v) skimmed milk for three hours at room temperature. The plates were washed with 
TBS-T and 1:1000 diluted anti-HS A-IgG in TBS was added to each well and incubated 
for one hour at 37°C. After the usual washing steps the wells were again coated with 
100 ^ il of 1:3000 diluted goat anti rabbit HRP conjugate and again kept for one hour at 
37°C. After the washing steps the peroxidase reaction was initiated by the addition of 
the substrate tetramethylbenzidine/ H^O, and arrested by the addition of 4.0 N H^SO .^ 
For improving the sensitivity the plates treated with anti-HS A-IgG and HRP conjugate 
were further incubated with anti-HSA-IgG, washed with buffer and again incubated 
with the conjugate. The alternate incubation with the anti-HSA-IgG and the conjugate 
were performed for the desired number of cycles. Peroxidase activity measured under 
standard conditions. 
3.1.11 Dot blot/western blot 
For immunodetection of HSA dots, appropriate quantities of the protein dissolved 
in 0.02 M sodium phosphate buffer pH 7.4 were applied on the nitrocellulose strips 
with the help of a micro syringe. The strips were blocked with 2% (w/v) solution of 
skimmed milk in the buffer for two hours, washed thoroughly with wash buffer (0.01 
M sodium phosphate buffer containing 0.15 M NaCl and 0.05% tween-20) and 
incubated in petridishes containing 0. Img/ml anti HSA IgG at 37°C for one hour. The 
strips were again washed with the wash buffer and further incubated with the goat anti-
rabbit IgG-HRP for one hour at 37°C. After washing the strips thoroughly once again 
with wash buffer, they were stained by incubating with 4-chloro-1 -naphthol reagent 
(Hawkes et al, 1982). For the layering steps, the unstained strips were reincubated 
with anti-HSA-IgG, washed and incubated once again with the goat anti-rabbit-IgG-
HRP conjugate. The incubation cycles with primary antibody and secondary antibody 
enzyme conjugated were repeated as desired prior to staining for the bound HRP. 
HSA was subjected to polyacrylamide gel electrophoresis (Laemmli, 1970) and 
electrophoretically transferred on to nitrocellulose (Towbin et al, 1979) at 4°C in 
Hoeffer Series TE transfer apparatus operating at 100 V for twelve hours. Transfer 
buffer contained 20% (v/v) methanol, 192 mM glycine and 25 mM tris. The bands 
were visualized by incubating the strips first with the primary antibody followed by 
washing and then with the conjugate for the desired number of times as described 
before staining with the 4-chloro-1-naphthol reagent. 
3.2 Colorimetric Analysis 
3.2.1 Determination of protein concentration 
Protein was estimated by the method of Lowry etal{\9S\). Aliquots of protein 
solution were taken in a set of tubes and final volume made up to 1 ml with 0.01 M 
sodium phosphate buffer, pH 8.0. Five ml of alkaline copper reagent (containing one 
part of 0.5%) (w/v) copper sulpahte, \% (w/v) sodium potassium tartarte and fifty 
parts of 2%) (w/v) sodium hydroxide was added, followed after 10 minutes of incubation 
at room temperature with 0.5 ml of 1.0 N Folin - Ciocalteu's phenol reagent. The 
tubes were instantly vortexed. The colour developed was read at 660nm after 30 
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minutes against the reagent blank. A standard curve was prepared using BSA as 
standard. 
3.2.2 Carbohydrate estimation 
The procedure described by Dubois (1956) was followed. Two ml aliquots 
containing 10 to 70 i^g of carbohydrate was pipetted into a test tube and 0.05 ml of 80 
% (v/v) phenol added. This was followed by addition of 0.5 ml of concentrated sulphuric 
acid, the stream of acid being directed against the liquid surface rather than against the 
side of the test tube in order to obtain good mixing. The tubes were allowed to stand 
for 10 minutes. Thoroughly mixed and again incubated for 20 minutes at 30°C. The 
colour intensity was measured at 490 nm for quantitation of hexose content. Glucose 
was used as the standard. 
3.2.3 Amino group estimation 
The amino groups of protein were determined by the method of Habeeb (1966) 
with slight modification. Suitable aliquots of the protein sample were dissolved in 1.0 
ml of 0.1 M sodium tetraborate buffer, pH 9.3, 25 \i\ of 0.3 M TNBS added and the 
tubes agitated instantly to ensure complete mixing and allowed to stand for 30 minutes 
at 25°C. Absorbance of the yellow colour developed was recorded at 420 nm against 
a reagent blank. Glycine was used as standard amino acid. 
3.2.4 Assay of pepsin 
Pepsin activity was assayed according to the protocol of Anson (1932). For the 
determination of the proteolytic activity of pepsin, appropriate aliquots of enzyme 
(3 mg pepsin in 0.2 M sodium acetate buffer, pH 4.5) were incubated with 1 mi of 2 % 
(v/v) hemoglobin in 0.06 N HCl. The reaction was allowed to proceed at 37''C for 20 
minutes. The reaction was stopped by the addition of 10 % (w/v) TCA. Acid insoluble 
material was removed by centrifligation at 1,000g for 15 minutes. The supernatant was 
analyzed for acid soluble peptides with Folins reagent (Lowry et ai, 1951). 
41 
1 mole of pepsin is the amount that digest 1.0 ^mole of hemoglobin to TCA 
soluble peptides/ minute at 37°C. 
3.3 Chemical modification of pepsin 
A solution of histidine (6mg/ml) in distilled water was mixed with 0.5 % (w/v) 
glutaraldehyde and incubated at room temperature for two hours. The glutaraldehyde 
linked histidine was loaded on 1 ml of a Cu^^-IDA sepharose. The matrix was washed 
with distilled water and the modified histidine was eluted with 5.0 ml of 10 mM EDTA. 
The preparation was mixed with 3mg/ml of pepsin in 0.2 M sodium acetate buffer pH 
5.5 and incubated for three hours. The sample was dialyzed extensively against the 
same buflFer. This pepsin preparation was again loaded on Cu^*-ID A and eluted with 
10 mM EDTA to obtain modified pepsin. 
3.4 Immobilized metal ion affinity chromatography (IMAC) 
Immobilized metal ion affinity chromatography (IMAC) was perfonned by using 
the fast flow, Imino Diaacetic Acid (IDA) - Sepharose (Nisonoff e? ai, 1960). IDA-
Sepharose was washed with 50 mM EDTA and 500 mM NaCl (pH 8.0). CuCl^  solution 
(20mM) was used to load the matrix with Cu^ ^ ions. The matrix was then washed with 
the operating buffer (50mM Tris-HCl, 100 mM NaCl, pH 7.5) and mixed with the 
dialyzed extract. After incubation for one hour at room temperature, the unbound F(ab)'2 
was collected by centrifugation at 1,000g. 
3.5 Slab gel electrophoresis 
3.5,1 Polyacrylamide gel electrophoresis (PAGE) 
Electrophoresis was performed essentially according to the method of Laemmli 
(1970) using the slab gel apparatus manufactured by Biotech, India. A stock solution 
of 30 % acrylamide containing 0.8 % bisacrylamide was mixed in appropriate proportion 
to give the desired percentage of gel. It was then poured into the mould formed by two 
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glass plates (8.5 x 10 cm) separated by 1.5mm thick spacers. Bubbles and leaks were 
avoided. A comb providing a template for seven wells was quickly inserted into the gel 
film and polymerization allowed to occur. After 15 - 20 minutes, the comb was removed 
and the wells were cleaned, overlaid with running buffer. Samples containing 15-35 
|ag protein mixed with equal volume of sample buffer (containing 10% (v/v) glycerol, 
0.06 M tris HCl, pH 6.8 and traces of bromophenol blue as tracking dye) were applied 
to the wells. Electrophoresis was performed at 100 V in the electrophoresis buffer 
containing 0.025 M tris and 0.2 M glycine until the tracking dye reached the bottom of 
the gel. 
3.5.2 Sodium dodecyle sulphate polyacrylamide gel elecrophoresis 
(SDS-PAGE) 
Sodium dodecyl sulphate (SDS) was performed by the tris-glycine system of 
Laemmli (1970) using slab gel electrophoresis apparatus, manufactured by Biotech 
India. Concentrated stock solution of 30 % acrylamide containing 0.8 % bisacrylamide, 
1.0 M tris (pH 6.8 and 8.8) and 10 % SDS were prepared and mixed in appropriate 
proportion to give the final required percentage. It was poured in the mould formed by 
two glass plates (8.5 x 10 cm) separated by 1.5mm thick spacers avoiding leakes and 
bubbles. A comb providing a template for seven wells was quickly inserted into the gel 
before the polymerization began. The comb was removed once the polymerization 
was complete and wells were overlaid with the running buffer. Protein samples were 
prepared in the sample buffer containing 1 % (w/v) SDS, 10 % (v/v) glycerol, 0.0625 
M tris HCl, pH 6.8 and traces of bromophenol blue as tracking dye and where required 
5 % f3-mercaptoethanol. The samples were boiled at 100°C for five minutes. 
Electrophoresis was performed in electrophoresis buffer containing 0.025 M Tris and 
0.2 M glycine at 100 V till the tracking dye reached the bottom of the gel. 
3.5.3 Staining procedures 
After the electrophoresis was complete the gels were removed and the protein 
bands were visualized by staining. 
(a) Coomassie brilliant blue staining 
Protein bands were detected by staining with 0.1 % coomassie brilliant blue 
R-250 in 40 % Isopropanol and 10 % acetic acid. The staining was carried out with 
10% glacial acetic acid. 
(b) Silver nitrate staining 
The procedure described by Merril et al (1982) was followed. After 
electrophoresis the protein bands were fixed by rapidly immersing in a mixture of 40 % 
(v/v) methanol and 10 % (v/v) acetic acid for one hour with constant shaking. The gel 
was washed with 10% methanol and 5 % (v/v) acetic acid twice, each time for 15 
minutes to allow the gel to swell to normal size. This was followed by incubation in 3.4 
mM potassium dichromate solution containing 3.2 mM nitric acid for 15 minutes and 
washing with distilled water. The washed gel was then immersed in 12 mM silver nitrate 
solution for 20 minutes and then again washed with distilled water and transferred to 
280 mM solution of sodium carbonate containing 0.5% formaldehyde to make the gel 
alkaline. The reaction was stopped after 10 minutes by transferring the gel to 3% 
acetic acid solution for 5 minutes. The gels were washed 4 to 5 times with distilled 
water and finally stored in distilled water. 
3.6 Spectral Analysis 
3.6.1 UV absorption spectroscopy 
The UV absorption spectra of native and modified pepsin was obtained by 
measuring the absorption between 200 - 400 nm in a Shimadzu spectrophotometer 
using a cuvette of 1cm pathlength. Two hundred micrograms of native and modified 
pepsin in a total volume of 1 ml was taken for spectral analysis. 
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3.6.2 Flourescence spectroscopy 
Native and modified pepsin was analyzed by measuring intrinsic fluorescence at 
25 iO-l^C in Hitachi F 2000 spectroflourometer (Tokyo, Japan). The protein was 
excited {X^^ at 280 nm and corrected emission spectra was recorded with extinction 
and emission band width of 10 run. Appropriate controls containing the substances 
used for the treatment were run and corrections were made wherever necessary. 
To study the cumulative effect of tyrosine, tryptophan and phenylalanine the protein 
was excited at 280 run. The temperature was maintained at 22°C by thermostating the 
cuvette housing during the measurement. The time of mixing was defined as t = 0. 
3.6.3 Circular Dichroism spectroscopy 
CD of native and modified pepsin were measured in a Jasco 720 
spectropolarimeter equipped with a temperature controlled sample cell holder. Spectra 
were recorded w^th a scan speed of 20 nm/minutes and with a response time of one 
second. Each spectrum was the average of two scans. Measurement in the far UV 
(200 - 250 nm) were taken using pepsin concentration of about 500 nM (ie about 
0.35 gm /litre) with a 1 mm path length cell. Whereas cells with 10 mm path length and 
pepsin concentrations of about 1.5 i^ M (ie about 1.2g/litre) was used in the near UV 
(200 - 300 nm). For each sample the buffer was used as blank. 
The results were expressed as mean residual ellipticity (MRE) in deg.cmldmol-1. 
Which is defined as 
MRE = e^ ^^  (m deg)/( 10 x n x 1 x Cp) 
Where 9^ ^^  is the CD in millidegree, n is the number of amino acid residues, 1 is 
the path length of the cell and Cp is the mole fraction. 
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3.7 Size exclusion high performance liquid chromatography (HPLC) 
Analysis of the FCab)'^  formed was carried out using an HPLC apparatus 
equipped with a gel filtration column (Protein Pak® Diol (OH)), 10|im, (7.5 x 300nm), 
equilibration, calibration and fractionation were carried out at room temperature with a 
0.4ml/min flow rate of 50 mM sodium phosphate and 150 mM NaCl (pH 7) buffer. 
The protein concentration in the eluate was monitored by its absorbance at 280 nm. 
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4.0 Results 
4.1 Immunogenicity of HSA and cross reactivity of anti HSA antibodies 
Human serum albumin used for the study was quite immunogenic and readily 
induced antibody formation in rabbits. Pre-immune and immunized antisera from 100 
to 100,000 dilution was coated in the wells for titre determination. After blocking of 
the wells with skimmed milk, they were again incubated with the enzyme conjugate. 
The plates were then developed for the peroxidase activity. HSA was found to be 
highly immimogenic, as it gives a titre of 31,622 (Fig 4.1). Sharp precipitin lines were 
obtained on immimodiffusion of anti-HSA antiserum and the DEAE fraction against 
HSA (Fig 4.2 A). In Fig 4.2(B) the precipitin lines obtained show that antisera raised 
against HSA readily cross reacted with human serum but not with bovine serum. 
4.2 Immunoaffinity layering 
4.2.1 Immunodot analysis of HSA by immunoafHnity layering 
Earlier studies from others (Alvarez-Kaza, 1993; Vanderberg, 1994) and from 
this laboratory (Farooqi et al., 1999) have shown that amounts of enzyme immobilized 
on a solid surface can be raised several folds by alternate incubations with the enzyme 
and anti-enzyme antibody. The strategy was described as immunoafFmity layering. It 
was envisaged that the strategy could be used to enhance the binding of secondary 
antibody-enzyme conjugate to the enzyme fixed on nitrocellulose and incubated with 
primary antibody. To enhance the sensitivity of the standard immunodot analysis 
procedure, immunoaffinity layering was performed with anti-HSA antibodies and the 
goat anti-rabbit IgG-HRP conjugate. HSA dissolved in 10 mM sodium phosphate 
buffer pH 7.4 was applied as spots on the nitrocellulose strips. A set of four strips 
prepared thus contained spots bearing 22.6 pg to 22.6 [ig of HSA . The strips were 
blocked with skimmed milk in order to prevent non specific binding. They were then 
thoroughly washed with PBS-T buffer and incubated with anti-HSA-IgG for one hour, 
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Figure 4.1 Titre determination of the raised antisera by ELISA 
Ninty six well microtitre plate was loaded with serially diluted antisera. 
Ajfter blocking with skimmed milk and washing with the wash buffer the 
plate was again incubated with the enzyme conjugate. The enzyme activity 
was read at 405 nm. For details see the text. 
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Figure 4.2 (A) Ouchterlony double diffusion of HSA against anti-HSA 
antiserum and IgG fractions isolated thereof. 
Rabbits were immunized with HSA. The antiserum obtained was 
fractionated to isolate the P-globulin fraction as detailed in the text. The 
central well contained 30|i)g of HSA. Well a, 30^g of immunize serum; 
well b, 30|Xg of 20-40% ammonium sulphate cut and well c, BOp-g of 
DEAE fraction. 
(B) Ouchterlony double diffusion of anti-HSA-IgG against purified 
HSA, Human serum and BSA 
Rabbits were immunized with HSA. The antiserum obtained was 
fractionated to isolate y-globulin fraction as detailed in the text. The 
central well contained 50)J,1 of antiserum. Well 1 and 2 had 30ng of BSA 
and HSA respectively and well 3 contained 50|il of human serum. 
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followed after thorough washing with the conjugate for the same duration. Strip I was 
stained for the peroxidase activity while strips II, III and IV were again incubated, 
after washing with bufifer, with anti-HSA-IgG followed by the conjugate, prior to staining. 
After an additional incubation with the primar)' antibody and the conjugate, strip II was 
stained for the peroxidase activity. Strip III and IV were carried through additional one 
and two incubation cycles respectively prior to staining for peroxidase activity. 
Fig 4.3 shows the quantity of HSA readily detectable under standard conditions 
used was 22,600 pg, although the sample bearing 2,260 pg of HSA was also visible as 
a very faint spot. The intensity of the HSA spots increased remarkably and step-by-
step on further incubations with anti-HSA-IgG and the conjugate, and those bearing 
far lower concentrations of HSA, not detectable under standard conditions, also became 
visible. As evident from Fig 4.3, the HSA spot bearing 22.6 pg of the protein was also 
readily detectable after four incubation cycles with anti-HSA-IgG and the conjugate. 
While it was possible to further increase the sensitivity of the procedure by increasing 
the number of the incubation cycles with anti-HSA-IgG and the enzyme conjugated 
secondary antibody, this was accompanied by a marked increase in background staining. 
4.2.2 Effectof time of incubation 
Attempts were made to ascertain if the enhancement in the observed sensitivity 
of detection of HSA with multiple incubation assays described in the previous experiment 
were not merely related to the extended durations for which HSA was exposed to the 
primary and secondary antibodies. For this purpose eight nitrocellulose strips each 
bearing 22,600 pg, 2,260 pg, 226 pg and 22.6 pg of protein applied as spots a, b, c 
and d were incubated for var>'ing intervals with primary antibody followed by incubation 
with the conjugate under standard conditions. 
As evident from Fig 4.4 in the strip I incubated for 10 minutes with primary 
antibody, only the spot bearing 22,600 pg of antigen was barely visible while the other 
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Figure 4.3 Immunodot analysis of HSA using the anti HSA antibody and HRP 
conjugate by multiple incubation assay. 
Nitrocellulose strips bearing different HSA concentration were incubated 
with primary antibody and enzyme conjugate for layering process. Dot 
a, 22.6 pg; b, 226 pg; c, 2,260 pg; d, 22,600 pg of HSA. I, II, III and IV 
indicates the number of layers the strip is subjected to. 
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Figure 4,4 Effect of incubation time on immunodot assay. j 
Nitrocellulose strips bearing different antigen (HSA) concentrations were 
subjected to dot blot analysis. Dot a, b, c and d contained 22,600 pg, 
2,260 pg, 226 pg and 22.6 pg of HSA respectively. Strips I, II III IV V 
VI and VII were subjected for 10 min, 15 min, 30 min, 1 hr, 4 hr, 8 hr 
and 16 hr respectively for each primary and secondary antibody 
incubation. 
VIII 
c d 
three spots containing 2,260 pg, 226 pg and 22.6 pg of HSA were not detectable. In 
strip II the intensity of the dots bearing 22,600 pg was somewhat increased, while strip 
III incubated for 30 minutes and then stained for peroxidase activity showed clear 
intensification of the spot with 22,600 pg of HSA and that containing 2,260 pg of HSA 
became clearly visible. In case of strip IV which was subjected to 1 hour incubation, 
the 22,600 pg spot of HSA became more intense accompanied by significant increase 
in the intensity of spot containing 2,260 pg of the antigen. Strip V, VI and VII that were 
incubated with the antibody for 4, 8 and 16 hours respectively showed no further 
improvement in the intensity of the spots. Longer incubations were also ineffective in 
rendering the 226 pg and 22.6 pg of HSA visible. Incubations beyond 8 hours infact 
resulted in decrease in the intensity of the spots supporting the observation of Gershoni 
(1984) that antigen-antibody complex may dissociate after long incubations. 
4.2.3 Immunodot analysis of HSA with intact anti HSA-IgG and F(ab)'j derived 
thereof 
In view of the probability of secondary antibody component of the conjugate 
recognizing the non-Fc regions of the primary antibody, it was envisaged that removal 
of the Fc portion of the latter may improve the binding process by decreasing the steric 
hindrance. Experiments were therefore undertaken to investigate the usefulness of the 
replacement of anti-HSA-IgG with the F(ab)', prepared thereof on the sensitivity of 
HSA detection by the multiple incubation procedure. Purified HSA was spotted on 
nitrocellulose strips and five spots of varying HSA concentrations were applied on two 
strips. While one strip was taken through four incubation cycles with anti-HSA-IgG 
followed by goat anti-rabbit IgG-HRP conjugate as described earlier, the other strip 
was subjected to the alternate incubations with anti-HSA- ^{ah)\ and the conjugate. 
Fig 4.5, shows a comparison of immunodot analysis of HSA using anti-HSA-IgG and 
F(ab)', derived thereof after four incubation cycles. The improvement in sensitivity as a 
result of substitution of F(ab)'2 (strip A) for IgG (strip B) was not very high but significant. 
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Figure 4.5 Immunodot analysis of HSA with intact anti-HSA-IgG and F(ab)' 
derived thereof. 
Nitrocellulose strips bearing dififerent HSA concentrations were subjected 
to immunoaffinity layering with intact anti-HSA-IgG (B) or F(ab)'2 
derived thereof (A) and goat anti-rabbit-HRP conjugate after four 
incubation cycles. Dot a, 11.3 pg; b, 22.6 pg; c, 226 pg; d, 2,260 pg and 
e, 22,600 pg of HSA. 
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The spot bearing even 11.3 pg of HSA was clearly visible after four incubation cycle 
involving F(ab)'2 and the intensities of the spots bearing higher concentration of the 
proteins increased when compared with those stained after multiple incubations using 
intact anti-HSA-IgG. Removal of the Fc region thus appears to facilitate a moderate 
enhancement in binding of secondary antibody conjugate, presumably by making antigen 
binding domains on FCab)'^  region more accessible. 
4.2.4 Immunoaffinity layering using native and glutaraldehyde crosslinked anti 
HSA-IgG 
An attempt to improve the sensitivity of detection was also made using anti-
HSA-IgG crosslinked with glutaraldehyde. As shown in Fig 4.6, anti-HSA-IgG migrates 
as two bands corresponding to light and heavy chain and the IgG was transformed to 
high molecular weight adduct on treatment with gluteraldehyde. The preparation cross 
linked with 0.5% glutaraldehyde did not enter the gel on electrophoresis indicating the 
very high molecular weight nature of the adduct. Eight strips spotted with 15.6 pg, 
156 pg, 1,560 pg and 15,600 pg of HSA as dots a, b, c and d respectively. Four were 
incubated with anti-HSA-IgG (Fig 4.7, Panel A) and four processed with glutaraldehyde 
crosslinked anti-HSA-IgG, (Fig 4.7, Panel B). In strip I, Panel (A) the dot bearing 
15,600 pg of HSA is very clear while that with 1,560 pg is visible as a very faint spot. 
In contrast in strip I, Panel (B) even the dot bearing the 156 pg of antigen is clearly 
detectable. While the dots bearing 15,600 pg and 1,560 pg were also more intense as 
compared to Panel (A). 
4.2.5 Immunodot analysis of HSA using affinity purified anti-HSA specific 
antibody 
Experiments performed thus far were performed using the IgG fraction isolated 
from the immune sera. Specific antibodies against HSA were isolated by affinity 
purification using HSA coupled to CNBr activated Sepharose 4B following the published 
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Figure 4.6 Gel electrophoresis of glutaraldehyde treated anti-HSA-IgG 
Anti-HS A-IgG was treated with glutaraldehyde and characterized using 
10% acrylamide gel in presence of P-mercaptoethanol. The gel was 
stained and de-stained according to the procedure given in the text. 
Lane a and b contained 0.5% and 0.05% glutaraldehyde treated 
preparations. Lane c contained native anti-HSA-IgG. 
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Figure 4.7 Immunodot analysis of HSA by immunoaffinity layering using 
native anti HSA-IgG (A) and gluteraldehyde linked anti-HSA-IgG 
(B). 
Strips of nitrocellulose membrane bearing 15.6 pg, 156 pg, 1,560 pg 
and 15,600 pg in dots a; b; c and d respectively. The strips were carried 
through One (I), two (II), three (III) and four (IV) incubation cycles as 
described in the text. 
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procedure (Stults, 1989). The preparation obtained thus contained 5mg/10ml of HSA. 
HSA specific antiserum was allowed to bind to the HSA-Sepharose 4B affinity column. 
The column was washed to remove any unbound IgG and the specific IgG eluted with 
0.1 M glycine HCl buffer pH 3.5. These immunoaffinity purified anti-HSA antibodies 
were used to perform immunodot analysis of HSA. Four nitrocellulose strips were 
spotted with 8.2 pg, 82 pg, 820 pg and 8,200 pg of HSA as dots a, b, c and d 
respectively. The strips were first blocked with skimmed milk and then incubated with 
affinity purified anti-HSA-IgG for 1 hour and with the conjugate also for 1 hour at 
37°C. Strip I was stained for the peroxidase activity, and strip II, III ans IV were 
taken through further incubation cycles (Fig 4.8). The dot bearing the 82 pg of antigen 
was very faint but detectable by the standard assay procedure. In the strip subjected 
to two cycles of incubation 82 pg spot could be seen clearly. The 8.2 pg spot was also 
visible in strip III as a faint spot. After four incubation cycles, 8.2 pg of HSA spot 
could also be clearly seen. The intensity of the spots also increased with each successive 
incubation cycle. The sensitivity of detection however appeared to improve only 
moderately when affinity purified antibodies were used instead of the IgG fraction. 
4.2.6 Immunodot analysis of HSA in human serum using the multiple incubation 
assay 
Four nitrocellulose strips were spotted with varying amounts of human serum as 
five dots. The strips were then taken through one, two, three and four incubation 
cycles, as described earlier in experiments, and Fig 4.9 shows the result of the study. 
As evident, HSA in the human serum sample bearing 3,944 pg of protein was barely 
detectable by the standard procedure. Successive alternate incubations as described 
earlier caused the appearance of new spots and marked intensification of those already 
visible. At the end of four incubation cycles, the spot of the human serum sample 
bearing 32 pg of protein was also detectable as a faint spot while that containing 39 pg 
protein turned more intense. Considering that albumin constitutes about half of protein 
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Figure 4.8 Immunodot analysis of HSA using affinity purified anti HSA-IgG 
on nitrocellulose strips by multiple incubation assay. 
Nitrocellulose strips bearing various concentration of HSA were carried 
through One (I), two (II), three (III) and four (IV) incubation cycles as 
described in the text. Dot a, 8.20 pg; b, 82 pg; c, 820 pg; d, 8,200 pg of 
HSA 
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Figure 4.9 Immunodot analysis of human serum by immunoaffmity layering. 
Nitrocellulose strips were spotted with whole human serum of different 
dilutions and subjected for four incubation cycles with anti-HSA-IgG 
and goat anti-rabbit-HRP conjugate. Dot a, 32 pg; b, 39 pg; c, 394 pg; 
d, 3,944 pg; e, 39,440 pg; of protein. I, II, III and IV indicates the 
number of layers the strips are subjected to. 
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in plasma, the sensitivity of its detection in plasma samples appears to be comparable 
with that of purified HSA. 
4.2.7 Studies of albumin aggregation using multiple incubation assay 
The applicability of the multiple incubation procedure to detect HSA aggregation 
at low concentrations was also investigated. HSA was subjected to 7.5% gel 
electrophoresis under non denaturing conditions (Fig 4.10). The lanes a, b, and c 
contained 5.6 ng, 56 ng, and 560 ng of albumin respectively. Subsequent to 
electrophoresis the protein bands were transferred on to nitrocellulose membrane 
according to the Towbin's protocol (Towbin et a/., 1979). Strips of panel 1 - IV were 
subjected to single, two, three or four incubation cycles respectively with primary 
antibody and the conjugate as described earlier in the text. As evident from Fig 4.10, 
panel I (a), aggregation is barely visible in the sample containing about 5.6 ng of HSA 
that migrated as a fast moving major band and a very faint band migrating about 75% 
of its distance, presumably representing the aggregated form of the protein. The slow 
migrating band was visible somewhat more prominently in the sample bearing 56 ng 
but was very clearly visible in that with 560 ng of protein, which also showed the 
presence of an additional far slower moving bands. Further incubations with primaiy 
antibody and secondary antibody conjugate however resulted in visualization of 
additional bands and at the end of the four incubation cycles, even the sample bearing 
5.6 ng showed additional slow migrating bands. Evidently even at the lowest 
concentration of HSA used, formation of aggregates takes place, but the aggregates 
were apparently present at concentration below the limits of detection of the standard 
staining procedure. The aggregation could however be clearly visualized by the multiple 
incubation procedure and additional bands of various mobilities could be seen even in 
samples containing 5.6 ng of protein. 
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Figure 4.10 Multiple incubation assay showing albumin aggregation 
HSA was subjected to polyacrylamide gel electrophoresis and transferred 
to nitrocellulose membrane. Strips of panel I-IV were subjected 
respectively to single two, three and four incubation cycles with anti-
HSA-IgG and conjugate. Lanes a; b and c contains 5.6 ng, 56 ng and 
560 ng of protein. 
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4.2.8 Multiple incubation assay in ELISA 
Wells of the polystyrene microtitre plates were coated with various HSA 
concentrations ranging between 0.0001 pg to 1 |ig. They were blocked with 2% (w/v) 
skimmed milk, incubated with anti HSA-IgG for 1 hour at 37°C. This was followed by 
the incubation with goat anti-rabbit-HRP conjugate and estimation of the peroxidase 
activity colorimetrically. After four incubation cycles even 1 pg of antigen was detectable. 
Sensitivity appears to increase nearly 10 fold after four incubation cycles (Fig 4.11). 
4.2.9 Multiple incubation assay in ELISA using F(ab)'2 
The experiments described in section 4.2.8 was also performed using anti-HSA-
F(ab)'2 instead of intact IgG. Plates were coated with varying amounts of HSA ranging 
from 0.0001 pg to 1 fig. Following the same standard procedure for layering, the 
plates were developed for peroxidase activity. Fig 4.12, shows the result after four 
incubation cycles. With F(ab)\ 0.1 pg of antigen could be detected after four incubation 
cycles. This suggested significant improvement in sensitivity over the procedure that 
employed intact IgG. 
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Figure 4.11 Multiple incubation assay on ELISA plate 
Ninty six well microtitre plate bearing HSA (0.0001pg to lug) were 
incubated with anti-HSA-lgG and enzyme conjugate through One (I), 
two (II), three (HI) and four (FV) incubation cycles as described in the 
text. 
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Figure 4.12 Multiple incubation assay on ELISA plate using F(ab)'2. 
Ninty six well microtitre plate bearing HSA (0.000 Ipg to l|ag) were 
incubated with anti-HSA-F(ab)'2 and enzyme conjugate for multiple 
incubation process. Results shown are of plates taken through four 
incubation cycles. 
65 
0.7 
0.6 
0.5 -
g 0.4 
c 
CO 
€ 
I 0.3 
< 
0.2 
0.1 
0.0 
-
— • -
o 
~ 
1 
• Intact IgG 
F(ab)'2 
1 1 
d 
1 
o 
1 
o 
1 
o 
1 
o ' 
1 
. o 
1 
.o • 
1 
• O 
1 
10-10 10-9 10-8 10-7 10-6 10-5 10-4 10-3 10-2 10-1 100 
HSA (ng) 
5.0 Modification of pepsin 
5.1 Preparation of pepsin modified with histidine 
Porcine pepsin contains 328 aminoacid residues, including two arginines, one 
histidine and one lysine. Our preliminary experiments indicated that affinity of pepsin 
for IDA Sepharose was only moderate, presumably due to the presence of the single 
histidine residue. The lysine residue protrudes firom the surface behind the active site 
cleft on the C-terminal domain of porcine pepsin (Cottrell et al ,1995). It was therefore 
envisaged that additional histidine could be coupled to the side chain of lysine residue 
of the enzyme to facilitate stronger binding of the enzyme to the immobilized metal ion 
support. 
In order to achieve covalent attachment of histidine, 6 mg of the aminoacid was 
mixed with 20-fold molar excess of glutaraldehyde in a total volume of one ml 0.02 M 
phosphate buffer pH 7.4 and incubated at room temperature for two hours. Amino 
group content of the glutaraldehyde treated histidine was determined with the help of 
TNBS method (Synder and Sobosinsta, 1975) and at the end of the incubation it was 
observed that greater than 95% of the amino groups were modified. In order to remove 
unreacted glutaraldehyde, the mixture was loaded on one ml column of Cu-'^ -IDA 
Sepharose. The matrix was washed with distilled water and the bound histidine eluted 
with five ml of 20 mM EDTA. The eluted preparation of modified histidine was mixed 
with 3 mg of pepsin in sodium acetate buffer pH 5.5 in a total volume of 6.0 ml and the 
mixture incubated for three hours at 4°C. This mixture was again loaded on the Cu-"-
IDA Sepharose and the modified pepsin eluted with 20 mM EDTA. The eluted sample 
was extensively dialyzed against 200 mM sodium acetate buffer pH 3.5. The pepsin 
preparation retained 85% of enzyme activity after its treatment with glutaradehyde 
treated histidine. 
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5.2 Properties of modified pepsin 
5.2.1 Kinetic behaviour 
5.2.1.1 Effect of substrate concentration 
When pepsin catalyzed haemoglobin digestion was measured as a function of 
substrate concentration at 37°C in 0.2 M sodium acetate buffer pH 3.5, a typical 
Mechalis Menton behaviour was observed in both the cases of native and modified 
pepsin. The Line Weaver Burk plot indicated K^ values for native and modified pepsin 
preparations as 200 mM and 222 mM, indicating only a minor alteration in the affinity 
of the enzyme for protein substrate as a result of the chemical modification. The V^^ of 
the modified pepsin remained nearly unchanged (Fig 5.1). 
5.2.1.2 Effect of temperature 
Temperature activity profiles for native and modified preparations were 
investigated in 0.2 M sodium acetate buffer, pH 3.5 and shown in Fig 5.2. No alteration 
in temperature maximum was observed and both native and modified pepsin showed 
maximum activity at 40°C. However the modified pepsin retained a relatively higher 
fraction of maximum enzyme activity at temperatures above 40°C 
5.2.1.3 Effect of pH 
Activity profiles of native and modified pepsin were investigated in 0.2 M 
sodium acetate or sodium phosphate buffer at various pH at 40°C (Fig 5.3). The 
optimum pH value of the modified preparation was identical with that of the native 
enzyme. 
5.2.2 Electrophoretic behaviour 
The porcine pepsin modified as described above was dialyzed thoroughly against 
0.2 M sodium acetate buffer, pH 3.5 and subjected to electrophoresis. Fig 5.4 (.A.) 
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Figure 5.1 Line Weaver Burk Plot for haemoglobin digestion by pepsin and 
modified pepsin preparations. 
30 ^g of pepsin and modified pepsin preparations were incubated in a 
series of tubes with the standard assay mixture containing varying 
concentration of substrate under standard conditions, and the activity 
was determined. 
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Figure 5.2 Temperatute activity profiles of native and modified pepsin 
Aliquots of pepsin and modified pepsin were incubated at indicated 
temperatures for 15 minutes and assayed for enzyme activity under 
standard conditions of pH and substrate concentration. 
Figure 5.3 pH activity profiles of native and modified pepsin preparations. 
Aliquots of native and modified pepsin preparation were incubated in 
0.2 M sodium acetate (pH 3.0 - 5.0) or 0.2 M sodium phosphate 
(6.0 - 8.0) for 15 minutes and the activity determined under standard 
assay condition. 
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Figure 5. 4 (A) Gel electrophoresis of native and modified pepsin. 
Native and modified preparations were subjected to gel electrophoresis 
in 12.5% polyacrylamide in the presence of P-mercaptoethanol and SDS. 
Lane a, molecular weight markers; lane b, native pepsin (35^g); lane c, 
modified pepsin (35ng). 
(B) Molecular weight determination of modifled pepsin by Weber 
and Osborn procedure. 
The relative mobility of the standard marker proteins from the SDS gel 
(Figure 5.4 A) were plotted against logarithm of molecular weight using 
least square analysis. Arrows indicate the position of the native and 
modified pepsin. 
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shows the electrophoretic behaviour of pepsin in reducing SDS PAGE. As evident 
from the Fig 5.4 (A) there was a very slight difference in the mobility of modified and 
native pepsin, with modified pepsin migrating slighlty slower than native enzyme. The 
molecular weight of modified pepsin as calculated was 37.2 KDa and the native pepsin 
had a molecular weight of 35.8 KDa (Fig 5.4, B). 
5.2.3 Autolysis of pepsin and modified pepsin 
In order to compare the susceptibility to autolysis, native and modified pepsin in 
0.2 M sodium acetate buffer, pH 3.5 were incubated for 18 and 24 hrs at 40''C. SDS-
PAGE under reducing condition shows one major band for modified pepsin, and three 
in native preparation incubated for 18 hrs (Fig 5.5, lane d and e). Even after 24 hours 
the modified preparation showed only two major bands while native pepsin was cleaved 
to several fragments (Fig 5.5, lane b and c). A small band migating slower than pepsin 
was observed in the modified pepsin preparation incubated for 24 hours. 
5.2.4 Spectral studies 
5.2.4.1 Ultra violet spectroscopy 
The UV spectrum of native pepsin shows maximum absorbance at 277 nm, 
while modification resulted in slight alteration in the spectrum with a shift in the absorption 
maximum from 271 to 274 nm. There was observed a 3 nm blue shift with a decrease 
in the magnitude of absorbance (Fig 5.6). 
5.2.4.2 Fluorescence spectroscopy 
The histidine modified pepsin was also characterised for its fluorescence using 
an excitation wavelength of 280 nm over the range of 300 - 400 nm. As shown in Fig 
5.7 the emission spectra obtained gave maximum intensity at 368 nm, both for native 
and modified pepsin preparation, but showed a decrease in the magnitude of 
fluorescence intensity in case of the modified preparation. 
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Figure 5.5 Autolysis of native and modified pepsin 
Native or modified pepsin were subjected to SDS-polyacrylamide gel 
electrophoresis after their incubation for 18 or 24 hours at 40°C at pH 2. 
Lane a, molecular weight markers (98,68,43,29,20 and 14 KDa); lane b, 
modified pepsin after 24 hours incubation; lane c, native pepsin after 24 
hours; lane d, native pepsin after 18 hours; lane e, modified pepsin after 
18 hours; lane f, native pepsin at zero hour. 
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Figure 5.6 Ultravoilet spectra of native and modified pepsin 
UV spectra of native and modified preparations in 0.2 M sodium acetate 
buffer were taken at pH 3.5. The protein concentration was 200 |ig/ml 
and the pathlength was 1 cm. 
Figure 5.7 Fluorescence spectra of native and modifled pepsin 
Fluorescence spectra of pepsin and modified pepsin in 0.2M sodium 
acetate buffer at pH 3.5. The protein concentration was 200 ng/ml. 
Samples were excited at 280 nm and band width was 10 nm. 
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5.2.4.3 Circular dichroism of native and modified pepsin 
The far UV spectrum for native pepsin is characterized by the presence of a 
minima at 216 run (Fig 5.8). Modification of pepsin with glutaraldehyde Unked liistidine 
resuked in only a marginal alterations in the spectrum leading to a slight dip at 219 nm. 
The CD spectra in the near UV region reflects the contribution of aromatic side 
chains, disulphide bonds, and of prosthetic groups (Kuwajima, 1989; Dryden and 
Weir, 1991). Fig 5.9 shows the near UV-CD spectrum of pepsin in 250 - 300 nm 
range. Near UV-CD spectrum of native pepsin is characterized by a band at 258 nm 
and the modified pepsin also showed nearly similar spectrum. The small decrease in 
the MRE value indicates a slightly less ordered structure in case of the modified pepsin. 
5.2.5 Binding of native and modified pepsin on Cu^MDA Sepharose 
Native or modified pepsin (2mg/ml) were mixed and incubated with Cu^ -^IDA 
Sepharose at increasing pH (2 - 8) for one hour. The matrix was centrifuged and the 
amount of protein in the supernatant was used to calculate percent binding. Fig 5.10 
shows that at pH 2, both native and modified pepsin showed only about 19 % binding 
to IDA Sepharose. At pH 4, there was a slight increase in the binding of modified 
pepsin to IDA over native pepsin which shows only 20% binding. At pH 6 and 8 
modified pepsin showed a marked increase in binding to the support over the native 
enzyme. 
5.2.6 Elution of pepsin and modified pepsin bound to Cu^*-IDA with EDTA 
Elution profile of native and modified pepsin was studied at varying EDTA 
concentration. Native and modified pepsins were eluted with 5 ml of (4 - 24 niM) 
EDTA. Fig 5.11 shows that native pepsin elutes completely at 16 mM EDTA while 
modified pepsin elutes only 80 % under the condition. At 20 mM EDTA however both 
the preparations were eluted completely from the support. 
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Figure 5.8 Far UV-CD spectra of native and modified pepsin 
Experiments were carried out at 0.2 M sodium acetate buffer pH 3.5 
using 1 ml (0.35 mg/ml) of native ( ) or modified pepsin 
( ) solution in a 1 cm path-length cuvette after two scans from 
200 to 250 nm at room temperature under continuous nitrogen flush. 
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Figure 5.9 Near UV-CD spectra of native and modifled pepsin 
Spectra were generated using 1 ml (1.2 mg/ml) solution of native 
( ) and modified pepsin ( ) in a 1 cm path length cuvette 
after two scans from 250 to 300 nm at room temperature under 
continuous nitrogen flush. 
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Figure 5.10 Binding of native and modified pepsin to Cu'MDA Sepharose 
Native or modified pepsin was allowed to bind to Cu^^-IDA at a pH of 
2, 4 ,6 and 8 
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Figure 5.11 Elution profile of native and modified pepsin from Cu^ '^ -IDA 
Sepharose 
Native and modified pepsin bound to Cu^ -^IDA was eluted with increasing 
EDTA concentration. 
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5.3 Purification and pepsinization of IgG and F(ab)', formation. 
5.3.1 Purification of IgG from anti-HSA antiserum 
Commercial HSA (Sigma) is quite immunogenic in rabbits and readily elicited 
the formation of precipitating antibodies. Its higher titre generation is shown in 
Fig 4.10. 
For the purification of anti-HSA antibodies, the procedure described by Catty 
and Raykundalia (1988) was followed. The antisera were precipitated between 20 -
40 % ammonium sulphate saturation, and the precipitate dissolved in 20 mM sodium 
phosphate buffer pH 7.2, was subjected to ion exchange chromatography on a DEAE 
cellulose column (1.8x10 cm) equilibrated with 20 mM sodium phosphate buffer, pH 
7.2. Purification of IgG was followed by polyacrylamide gel electrophoresis performed 
in presence of SDS. Whole antiserum and ammonium sulphate fractions show bands 
corresponding to IgG and several other polypeptides (Fig 5.12, lane a and b). Nearly 
all other bands were removed after DEAE cellulose chromatography and the purified 
IgG preparation gave a single band (Fig 5.12, lane c) on electrophoresis. 
5.3.2 Molecular weight of IgG 
In order to determine the molecular weight of the isolated IgG preparation, SDS-
PAGE was run along bovine serum albumin (68 KDa), ovalbumin (43 KDa), carbonic 
anhydrase (29 KDa), soyabean trypsin inhibitor (20 KDa) and lysozyme (14.2 KDa) 
as markers (Fig 5.13 A). The molecular weight of the polypeptides of IgG was calculated 
as per the procedure of Weber and Osborn (1969) by plotting the mobility of marker 
proteins Vs the logarithim of their molecular weights (Fig 5.13 B). The position of the 
migration of IgG polypeptides corresponded to their apparent molecular weights of 48 
KDa and 25 KDa. 
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Figure 5.12 Purification of IgG 
IgG was purified by salt fractionation and DEAE cellulose 
chromatography, and subjected to SDS-PAGE. Lane a, rabbit serum; 
Lane b, 20 - 40% ammonium sulphate fration; Lane c, DEAE fraction 
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Figure 5.13 (A) SDS-PAGE of IgG during various stages of purification 
Antiserum, 20 - 40% ammonium sulphate fraction and fraction from 
DEAE cellulose and markers were incubated with sample buffer at 100°C 
for five minutes and subjected to 12.5% polyacrylamide gel 
electrophoresis in presence of SDS. Lane a, DEAE cellulose fraction; 
lane b, 20 - 40% ammonium sulphate fraction; lane c, antiserum; lane d, 
molecular weight markers. 
(B) Molecular weight determination by Weber and Osborn 
procedure 
The relative mobility of the standard marker proteins from SDS gel 
(5.13 A) was plotted against logarithm of molecular weight using least 
square analysis. Arrows indicate the positions of the large and small 
molecular weight peptides from the DEAE fraction. 
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5.3.3 Cleavage of IgG with modified pepsin and purification of F(ab)' by IMAC 
The IgG fraction obtained by ammonium sulphate fractionation and DEAE 
cellulose chromatography was subjected to proteolysis with the modified pepsin 
preparation to obtain F(ab)'2 fragments. Initially, the procedure described by Nisonoff 
et al (1960) for IgG cleavage by pepsin was followed. Two mg/ml of IgG solution was 
incubated with modified pepsin in a ratio of (1:100) at 40°C for 24 hours at pH of 4.5. 
The reaction was terminated by adding tris salt that increased the pH to 8. 
Fragmentation of the IgG was studied by SDS PAGE under reducing conditions. 
The gel shows the disappearance of the band corresponding to IgG with a significant 
increase in the band of higher mobility (Fig 5.14, lane b) suggesting the cleavage of 
IgG into VidbyjYc fragments. The faster moving protein bands presumably correspond 
to degraded Fc fragment. 
With a view to achieve the separation of F(ab)'2 generated from intact IgG/Fc, 
IMAC was used. Fig 5.14, lane a shows a single band with mobility corresponding to 
IgG inferring the complete binding of intact IgG, Fc and fragmented Fc to Cu-"-IDA 
Sepharose. 
Optimum conditions of IgG cleavage by modified pepsin, were evaluated by 
studying the dependence of the process on temperature , pH and time of incubation. 
5.3.3.1 pH dependent cleavage of IgG 
IgG (2 mg/ml) cleavage with modified pepsin preparation was investigated 
after 12 hours incubation at 40°C at various pH values between (3.5 to 5.0). The 
reaction was stopped by the addition of 0.2 MNaOH. Fig 5.15 shows that IgG was 
best cleaved at pH 3.5 while at pH 5.0 there was very little cleavage of IgG . At pH 
4.0, most of IgG was cleaved leaving only a faint band corresponding to heavy chain. 
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Figure 5.14 Pepsinization of IgG 
2 mg/ml IgG was exposed to pepsin at pH 4.5 at 37°C. The reaction was 
terminated after 24 hours by the addition of tris salt. Fragmented IgG 
and F(ab)'2 obtained was subjected to non reducing PAGE. Lane a, 
supernatant obtained after binding of the pepsin digested IgG on Cu^^ -
IDA Sepharose Intact IgG; Lane b, IgG treated with pepsin; Lane c, 
intact IgG. 
a b c 
Figure 5.15 pH dependent cleavage of IgG 
Pepsin digestion of the IgG was carried out at various pH values and the 
digest subjected to SDS-PAGE. Lane a, intact IgG; lane b; c; d and e, 
pepsin digests prepared at pH 5.0,4.5,4,0,3.5 respectively. 
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5.3.3.2 Temperature dependent cleavage of IgG 
IgG was cleaved with the modified pepsin preparation at pH 3.5, for 12 hours 
at various temperatures between 4°C to 40°C. Fig 5.16, lane b shows that the 
fragmentation of IgG was barely detectable at 4°C, while at 20°C cleavage was quite 
significant (Fig 5.16, lane c). Presence of a single band in the preparation exposed to 
protease at 40°C shows complete fragmentation of IgG (Fig 5.16, lane d). 
5.3.3.3 Time dependent cleavage of IgG 
IgG was incubated with modified pepsin preparation at pH 3.5 at various time 
intervals at 40°C, the reaction was stopped by adjusting the pH to 8 with 0.2 M NaOH 
and the reaction products characterized by SDS-PAGE. Fig 5.17, lane d shows that 
after one hour incubation nearly all the IgG was cleaved. 
5.4 Binding of F(ab) monomer to Cu-'-IDA Sepharose 
Experiments were performed to determine if the F(ab) monomers bind to IDA 
Sepharose. This was considered important since small amounts of the monomer may 
be formed during the proteolysis of IgG to F(ab)',. For the purpose 50 |ig of each 
F(ab)'2 and F(ab) obtained as described in methods were rhixed and loaded on Cu-'-
IDA Sepharose, and the unbound fraction was characterized by PAGE. Fig 5.18, lane 
b shows 2 bands corresponding to F(ab)', and Fab, lane a had only one band 
corresponding to F(ab)', indicating essentially complete binding of F(ab) monomer to 
the Cu-*-IDA Sepharose. 
5.5 Isolation of F(ab)\ from unfractionated serum 
Five hundered microlitres of serum was adjusted to pH 3.5 with the help of 
0.06 N HCl, digested with 500 |ig of modified pepsin at 40°C. After one hour 
incubation, the reaction was terminated with 0.2 N NaOH. One hundered \i\ of digested 
serum was loaded on 300 |il of IDA Sepharose loaded with Cu-', Fe-"^ , Ni-*, Co-* or 
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Figure 5.16 Temperature dependent cleavage of IgG 
SDS-PAGE of the pepsin digest of IgG carried out at various 
temperatures, assessed under reducing conditions. Lane a, Intact IgG; 
Lane b; c and d has IgG digested at 4°C, 20°C, 40''C respectively. Lane 
e, marker proteins (98,68,43,29,20 and 14 KDa). 
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Figure 5.17 Time dependent cleavage of IgG 
IgG digested with pepsin for various time intervals was subjected to 
SDS-PAGE. Lane a, marker proteins (98,68,43,29,20 and 14 KDa); 
lane b, intact IgG; lane c; d; e; f and g pepsin digests obtained after 30 
minutes, 1 hour, 4 hours, 8 hours and 12 hours respectively. 
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Figure 5.18 Binding of F(ab) monomer to Cu^MDA. 
A mixture of F(ab)'2 and F(ab) prepared as described in methods was 
incubated with Cu^"'-IDA-Sepharose. The unbound fracure was subjected 
to 7.5% non-reducing PAGE. Lane a, IDA supernatant; Lane b, mixture 
of F(ab)'2 dimerand F(ab) monomer. 

Figure 5.19 SDS-PAGE of serum digested with modified pepsin and binding to 
IDA-Sepharose loaded with various metal ions 
The serum digest as described in the text was allowed to bind to Cu^ "^ -, 
Fe^*-, Ni-^- and Zn^ -^ IDA Sepharose. Unbound fraction was subjected 
to PAGE in absence of |i-mercaptoethanol (Panel A) or in presence of 
P-mercaptoethanol (Panel B). 
Panel A, lane a, pepsin digest, lane b,c,d,e, and f had the supernatant of 
Fe^ -^, Cu^"-, Co^^-, Ni^ -^ and Zn^^-chelated IDA Sepharose. 
Panel B, lane a, pepsin digest, lane b,c,d,e and f contained the supernatant 
of Zn^*-, Ni-"-, Fe^^-, Co^ -^ and Cu-"- chelated IDA Sepharose. 
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Figure 5.20 High performance gel filtration chromatography of IgG and its 
pepsin digest. 
Rabbit IgG was digested with pepsin and the digest incubated with Cu^ ""-
IDA Sepharose. The samples were analyzed using a Protein Pak ® 
column. (A) Intact IgG, (B) Pepsin digest of IgG, (C) supernatant of 
IgG digest incubated with Cu^ "^ - IDA Sepharose. 
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Figure 5.21 High performance gel filtration chromatography of serum and its 
pepsin digest. 
Rabbit serum was digested with pepsin and the digest incubated with 
Cu^*- IDA Sepharose. The samples were analyzed using a Protein Pak* 
column. (A) serum, (B) pepsin digested serum proteins, (C) supernatant 
of serum digest incubated with Cu^*-IDA 
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tenninated by adjusting the pH of the reaction mixture to 8 with the help of 20 fil of 0.2 
M NaOH. The sample was centrifuged and the supernatant analyzed both by reducing 
and non-reducing SDS-PAGE. Fig 5.22 panel (A), lane b, c and Fig 5.22 panel (B), 
lane a, b shows a single band indicating the formation of F(ab)' . 
5.7.1 Isolation of F(ab)'j in a single tube from various mammalian species 
IgG was isolated from the sera of sheep, goat, buffalo, rabbit and rat. Prior to 
incubation with the reaction mixture, the pH of the IgG was adjusted to 3.5. The IgG 
solution (1 mg/ml) from each species was added to the tube, 0.2 M NaOH was added 
to stop the reaction after one hour incubation at 40°C. Supernatant collected was run 
on SDS-PAGE. IgG from all the species showed the presence of only F(ab)'2 in the 
unbound fraction (Fig 5.23). All the lanes give a single band confirming their 
homogeneity. 
5.8 Antigenicity of F(ab)'2 isolated from IgG 
Immunodiffusion was also performed to check the antigen binding affinity of 
F(ab)'2 preparation. Sharp precipitin lines were obtained on immunodiffusion of anti 
HSA- F(ab)'2, and affinity purified anti-HSA-F(ab)'2 prepared from the above 
procedure indicating the homogeneity of the preparation (Fig 5.24). 
Figure 5.22 Production of purified F(ab)'j from IgG in single tube. 
1 mg/ml IgG was incubated with modified pepsin, IDA-Sepharose and 
CuClj at pH 3.5 for 1 hour unbound fraction was subjected to SDS-
PAGE under reducing condition (Panel A), non reducing condition 
(Panel B) 
Panel A, lane a, marker proteins (98,68,43,29,20 and 14 KDa); lane b 
and c contains 40 and 80 |il of the unbound fraction. Panel B, lane a and 
b had 80 and 40 |J.l of unbound fraction respectively. 
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Figure 5.23 Preparation of F(ab)'2 from IgG derived from various mammals 
IgG derived from various mammalian sera were digested with modified 
pepsin and the reaction mixture purified on Cu(II)-IDA Sepharose. The 
supernatant was subjected to SDS-PAGE along with ^-mercaptoethanol 
as described in the text. Lane a; b; c; d and e had 50 ^\ of fraction that 
did not bind to IDA Sepharose from sheep, goat, buffalo, rabbit and rat 
respectively. 
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Figure 5.24 Ouchterlony double diffusion of anti-HSA- IgG and anti-HSA-IgG-
F(ab)'j against HSA. 
Rabbits were immunized with HSA antiserum obtained was fractionated 
to isolate the whole y-globulin and anti HSA IgG fraction (affinity 
purified) as detailed in the text. IgG obtained was treated with modified 
pepsin preparation to yield F(ab)'2 in the single tube incubation procedure. 
The central well contained 30|ig of HSA; well 1, anti-HSA antiserum; 
well 2, anti-HSA-IgG; well 3, F(ab)'2 derived thereof; well 4 and 5 had 
anti-HSA specific IgG and F(ab)'2 derived thereof respectively. 
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6.0 Discussion 
Enzyme coupled immunoassays are widely used in revealing antigen 
antibody interactions on solid matrices such as nitrocellulose membranes, in dot 
blot and western blot procedures, tissue sections, cell smear preparations as well 
as in ELISA. Immunoassays and analogous assay systems are of increasing 
importance both in basic and applied research as well as for routine diagnostic 
purposes. Sensitivity in most cases is the key problem in immunological detection 
systems. Until recently, there has been an explosive increase in the application of 
the technique in detection and quantitation of antigens/antibodies as well as in 
efforts to improve them (Towbin et al., 1984; Chu et al., 1989). Interesting 
variations involving the use of biotinylated antibodies and avidin conjugated 
enzymes have proved remarkably effective in improving the detection of dot blot 
analysis (Guedson et al, 1979; Ogata et al, 1983). 
In efforts to raise the sensitivity of Clark electrode based glucosensors, large 
amount of the enzymes have been assembled on Sepharose support as alternate 
glucose oxidase/polyclonal antiglucose oxidase IgG layers and the technique was 
described as immunoaffmity layering (Farooqui et al., 1999). 
The present work employs a similar strategy which is remarkably effective 
in increasing the limits of detection of protein antigens on nitrocellulose in dot 
analyses as well as after transfer from polyacrylamide gels and in ELISA. Studies 
described in chapter 4 shows that sensitivity of immunodetection of HSA on 
nitrocellulose strips can be raised upto 100-fold by repeated incubations with the 
primary antibody and the secondary antibody HRP conjugate prior to staining 
them with the substrate 4-chloro-1 -naphthol/H^Oj. The conjugate being oligomeric, 
is expected to have multiple binding sites for the primary antibody. On incubation 
of the conjugate with the nitrocellulose strips bearing HSA with bound primary 
antibody, binding occurs. A number of binding sites of the oligomeric conjugate 
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for primary antibody are however expected to remain free due to non availability 
or inaccessibility of the sites on the primary antibody. Consequently, when the 
strips are incubated further with anti HSA-IgG (primary antibody), additional 
binding of the later occurs. Some of the binding sites of the primary antibody thus 
bound to the complex may also remain free, similarly facilitating additional binding 
of the conjugate during subsequent incubations with the later. Continuation of the 
alternate incubations with the primary antibody and the conjugate may therefore 
result in the formation of multiple layers of primary antibody and the conjugate 
resulting in the association of large amount of the enzyme (HRP) with the antigen 
(Fig 6.1). This results in remarkable increase in the sensitivity of detection of the 
antigen. Fig 4.3 shows that quantity of HSA readily detectable by dot analysis 
using the standard procedure is 22,600 pg but a faint spot of the sample bearing 
2,260 pg of HSA was also visible. The intensity of the HSA spots increased 
remarkably on taking the strips through further incubation cycles and as evident 
from Fig 4.3 the spot bearing as low as 22.6 pg of HSA was also detectable after 
four incubation cycles. 
In order to eliminate the possibility that the longer duration of the incubations 
for which the strips are exposed to primary antibody and the conjugate during 
multiple enzyme assay, are responsible for the observed increased sensitivity, effect 
of extending the duration of incubation was studied with primary/secondary 
antibody. It is clear from the Fig 4.4 that there is no increase in the intensity of 
spots after one hour incubation and the intensity of spots of strips incubated for 4, 
6 and 8 hours was not higher than that incubated for one hour. Instead the intensity 
of spots actually decreased slightly after 8 hours of incubation time (Fig 4.4, strip 
VIII), supporting the observation of Gershoni (1984) that antigen-antibody complex 
may dissociate on long incubations. This study thus rules out that observed increase 
in the intensities of the spots after multiple incubations is not the result of more 
longer exposure to the primary antibody or the conjugate. 
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Figure 6.1 Diagrammatic representation of the multiple incubation procedure. 
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With a view to achieve improvement in the sensitivity F(ab)'2 fragments 
derived from anti HSA-IgG were used instead of whole IgG in the multiple 
incubation assay.The removal of the Fc portion from primary antibody decreases 
the steric hindrance for the binding of the conjugate and lowers non-specific binding 
(Ishikawa, 1983). Fig 4.5 shows that the spot bearing 11.3 pgofHSA was readily 
detectable after four incubation cycles when ¥(aby^ but not intact IgG was used. 
The observed improvement in sensitivity was however only moderate with an 
apparent 2-fold increase in the detection limit. 
In an attempt to further increase the sensitivity of detection of the antigen, 
usefulness of using crosslinked primary antibody vvas investigated. It was envisaged 
that oligomeric/poiymeric antibodies will be left with greater number of unoccupied 
antigen sites after binding to the antigen immobilized on the nitrocellulose. This 
would result in enhancement in the binding of the conjugate molecules and hence 
improved detection in the sensitivity. For this purpose anti-HSA-IgG crosslinked 
with the bifunctional crosslinking agent glutaraldehyde was used in place of the 
IgG in the multiple incubation assay. Glutaraldehyde treatment of the IgG resulted 
in the formation of large aggregates that did not enter the gel (Fig 4.6). Fig 4.7 
shows that the multiple incubation assay with glutaraldehyde linked primary 
antibody slightly improved the sensitivity of antigen detection and it was possible 
to detect 15.6 pg of HSA. There was approximately only 1.5-fold increase in 
sensitivity as compared to the standard multiple incubation procedure with 
crosslinked anti-HSA-IgG. The improvement in sensitivity achieved by using the 
crosslinked antibodies is not remarkable, presumably due to masking inactivation 
of some of the antigen binding sites as a result of cross linking. 
Use of affinity purified anti-HSA-IgG instead of IgG also resulted in only 
modest improvement in the sensitivity of the multiple incubation procedure. The 
sensitivity increase was nearly 2.7-fold as compared to the standard procedure 
(Fig 4.8). 
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The applicability of the multiple incubation assay for the detection of HSA 
in the unfractionated serum samples was also studied. HSA spot in the human 
serum sample was detectable by standard procedure only when an aliquot of serum 
bearing a minimum of 3.9 ng of protein was applied on the strip. The multiple 
layering procedure could however lower the detection limit in the serum sample 
to 32 pg, there by increasing the sensitivity about to 100-fold. This is in accordance 
with the observed increase in sensitivity while using pure HSA (Fig 4.9). 
Applicability of the multiple incubation assay for increasing the sensitivity 
of detection of HSA after electrophoresis and western blotting on nitrocellulose 
strips was also investigated. Albumin has been shown to aggregate at neutral pH 
especially when the concentration of the samples was high (Jordan et al., 1994; 
Katakam and Banga, 1995; Ortega-Vinuesa, 1998). It is usually inferred that 
aggregation is not significant at low protein concentration. As shown in Fig 4.10 
aggregation was barely visible with the standard procedure in 5.6 ng of HSA 
sample, but was clear after four inbubation with primary antibody and the enzyme 
conjugate. 
The multiple incubation strategy with the primary antibody and the conjugate 
also worked quite well in ELISA, and the sensitivity of the assy could be increased 
significantly (Fig 4.11). One pg of HSA could be quantitated after four incubation 
cycles, while the limit of the standard ELISA procedure was only 10 pg. Multiple 
incubations was also performed in ELISA using F(ab)'2, and it is evident from Fig 
4.12 that after four incubations 0.1 pg of HSA could be conventionally quantitated. 
The detection limit of all the procedures used are summarised in Table 6.1. 
The repetitive incubation with primary antibody and the conjugate as well 
as the process of washing between successive incubations makes the procedure 
time consuming. Taking into consideration the remarkable improvement in 
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Table 6.1 
Sensitivity of HSA detection/quantitation by the multiple incubation assay' 
Technique used 
Immunodot 
analysis 
Western blotting 
(HSA aggregation) 
ELISA 
Primary antibody 
Anti-HSA-IgG 
Anti-HSA-F(ab)'2 
Glutaraldehyde linked 
anti-HSA-IgO 
Affinity purified Anti-
HSA-IgG 
Anti-HSA-IgG 
Anti-HSA-IgG 
Anti-HSA- F(ab)'2 
Detection limit 
After single 
incubation 
cycle (pg) 
2,260 
1,700 
1,560 
820 
56,000 
10 
1 
After four 
incubation 
cycles (pg) 
22.6 
11.3 
15.6 
8.2 
5,600 
1 
0.1 
* The assays were performed using the secondary antibody-HRP conjugate and 
the standard procedure as described under methods 
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sensitivity achieved, the efforts may however be considered worthwhile. In addition 
considering that the antigen antibody interactions involved in the entire multiple 
incubation procedure are not different from those of the standard procedure, the 
specificity of the assay is not compromised. 
The multiple incubation approach with the moderate improvement in 
sensitivity of detection of the cells/tissue bound antigens/antibodies (Halveson et 
al., 1981; Lansdorp et al., 1984) and in the construction of biosensors (Farooqui 
et al., 1999) have been described earlier. To our knowledge amplification of 
sensitivity of detection on nitrocellulose membrane of the magnitude described in 
this study has not been achieved thus far. Naser et al (1990) described a single 
incubation multiple layer immune technique in which the immobilized antigen is 
incubated simultaneously with primary antibody and secondary antibody enzyme 
conjugate. While the author claims 4-20 fold improvement in sensitivity, this could 
not be substantiated in our laboratory due to precipitation of the immune complex 
from the solution during the incubation. 
In most instances of infection, parasite specific antibodies are more easy to 
detect and hence used as diagnostic tools. However diagnosis based on antigen 
may be more reliable although antigen concentrations present in blood even at the 
peak of infection period may be quite low. This together with the difficulty of 
obtaining adequate human biological samples for the assays, necessitates highly 
sensitive antigen detection procedures. The multiple incubation procedure described 
in this study may be very help ful in this respect. Another remarkably attractive 
feature of the procedure is its potential in increasing the sensitivity of antigen 
detection using commercial kits. 
The growing use of immunological assays requires rapid, reproducible 
protocols for preparation of fragments from polyclonal and monoclonal antibodies. 
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Preparation of FCab)'^  fragments by pepsinolysis is a well established procedure 
for producing antibody fragments that retain full binding activity but lack the 
effector functions conferred by the Fc domain (Wisonoffet al., 1960; Andrew and 
Titus, 1997). Removal of the Fc portion of the IgG also restricts the steric hindrance 
in the binding of antigen. Such FCab)'^  fragments have also proven very useful in 
experiments designed to analyze the role of the Fc segment in various biological 
functions (Turner et al., 1970). Enzyme cleaved antibodies are also widely used in 
the treatment of snake envenoming (Meyer et al., 1997; Moran et al., 1998). 
The classical method of preparation of F(ab)'2 involves the isolation of the 
y-globulin class of serum proteins, digestion with pepsin (Nisonoff er al., 1960) 
and final recovery of F(ab)'2 fragments by gel filtration (Jaquet and Cebra, 1965) 
or ion exchange chromatography (Clezardin et al, 1985). Such procedures as 
well as the simplified method of Madson and Rhodkey (1976), using digestion of 
whole globulin fraction are effective but quite laborious, time consuming and 
expensive. 
In the present study efforts have been made to develop a single step procedure 
for the production of F(ab)'2 from purified IgG as well as serum fractions. The 
metal chelate affinity binding technique described by Hale and Biedler, (1994) 
was exploited for the purification of the F(ab)'2 fragments. Hale (1995) has shown 
that metal chelate (Cu^*-IDA Sepharose) column is selective for the Fc portion of 
Immunoglobulin and the well conserved histidine rich region of C^3 domain is the 
principal specific site of interaction. The site is apparently well conserved among 
several immunoglobulin classes. Thus selective affinity for immobilized metals for 
the Fc portion of antibodies provides an effective technique for purification of 
F(ab)'2 which is devoid of Cj^ 3 domain and thus does not bind to the support. 
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The objective of the technique described here is to isolate F(ab)'2, free of 
pepsin used for the proteolytic cleavage of IgG, Fc fragment or the fragment 
thereof or any remaining intact IgG. In order to achieve the goal, it was necessary 
to ensure to have pepsin preparation that possessed strong affinity for the 
immobilized metal ions and this was achieved by attaching an additional histidine 
to the enzyme (Fig 6.2). The covalent attachment of a histidyl residue was 
accomplished by treating pepsin with glutaraldehyde treated histidine. Porcine 
pepsin contains a single lysine residue (Cottrell et al., 1995). The imadazole group 
is expected to be attached mainly at position 319 although the aldehyde treated 
histidine may react with other amino acid side chains as well (Habeeb et al., 1968; 
Fraenkel-Conrat and Olcott, 1968). The modified pepsin obtained exhibited 
remarkable higher affinity towards Cu '^^ -IDA Sepharose as compared to the native 
enzyme and could be purified by binding onto and elution from the support. 
Various kinetic and spectral parameters studied to investigate the behaviour 
of the modified pepsin. Fig 5.1 shows that there was only a marginal increase in 
the K^ value of modified pepsin, which suggest that the modification does not 
cause major alterations in conformation of the active site and hence the affinity 
for substrate. The modified preparation was almost equally active as native enzyme 
with identical V^^ ^ and exhibited unaltered temperature optimum. The temperature-
activity profile of the modified pepsin was also comparable with the native pepsin 
(Fig 5.2). The pH activity profiles however suggested that the modified enzyme is 
less resistant to extremes of pH as compared to native pepsin although both 
preparations have same pH optima (Fig 5.3). The result is in accordance with that 
of Cottrell et al (1995), who showed a decrease in the inactivation pH for the 
pepsin in which lysine was modified with methionine with no appreciable shift in 
the pH optimum. 
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Figure 6.2 Diagrammatic representation of the procedure of coupling 
histidine to lysine residue of pepsin with the help of glutaraldehyde 
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In SDS-PAGE the modified pepsin migrated signifantly slowly as compared 
to the native pepsin indicating an increase in molecular weight. The molecular 
weight of modified pepsin comes out to be 1.4 KDa more than the native pepsin, 
which is higher than what is expected if the attachment occurs of a single 
glutaraldehyde linked histidine to the lone lysine of the enzyme. Evidently the 
modified histidine may have reacted with residues other than lysine as described 
earlier. Alterations in the rigidity of the polypeptide due to the chemical modification 
may also be responsible for the slower mobility of the modified pepsin in SDS-
PAGE (Fig 5.4). 
The decrease in the activity of pepsin at higher temperature may be related 
both to the unfolding of the polypeptide and autolysis. One can therefore speculate 
that modified pepsin being more resistant to autolysis (Fig 5.5) may retain greater 
fraction of enzyme activity at higher temperature. While the side chain residues of 
aminoacids that undergo modification as a result of glutaraldehyde treatment may 
not contribute to the pepsin susceptible bonds (Fruton and Bergmann, 1939; 
Konigsberg et al., 1963), the observed lower autolysis of modified pepsin may be 
related to a minor alteration in conformation. It is also difficult to explain the 
presence of the band migrating slower than pepsin in the modified preparation 
incubated for 24 hours (Fig 5.5). It has been reported that chemical modifications 
of several enzymes including proteases results in improving resistance to autolysis 
and inactivation (Bogacheva et al., 1977; Nakajima et al., 2002). The improvement 
in stability at high teniperature is certainly a significant advantage in their utilization 
in the degradation of proteins, since higher temperatures in addition to contributing 
towards enhanced reaction rates also result in unfolding of the substrate proteins 
(Inadaera/., 1995). 
The UV absorption spectrum of modified pepsin showed a 3nm blue shift 
(Fig 5.6) indicating that hydrophobic groups of the modified enzyme may be slightly 
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more buried as compared to native enzyme. However the fluorescence spectrum 
depicted a decrease in the intrinsic fluorescence (Fig 5.7) obtained for modified 
pepsin indicating some environmental changes around the chromophoric groups 
as a consequence of the attachments of histidine to the lysine residue of porcine 
pepsin. The quenching can be attributed to the shifting of some tryptophan residues 
to a more polar environment. (Friedfelder, 1982). 
Circular dichroism (CD) is widely used for studying the conformational 
changes of proteins in solutions (Proven-Cheer and Glockner, 1981). Fig 5.8 shows 
the far UV CD spectrum for pepsin and modified pepsin with the characterstic 
minimum at 215 run for acid proteases (Tello-Sollis et al., 1995; Allen et al., 
1990). In the spectral region of 200 - 250 nm, the CD signal of proteins is mainly 
due to its secondary structure (Manavalan, 1983; Hennessay et al., 1981). The 
CD spectra obtained for modified pepsin and native pepsin have no significant 
difference, indicating no major change in the secondary structure of modified pepsin. 
Although the spectrum for modified pepsin also shows a slight dip at 219 nm, 
inferring a stable ^-sheet structure for modified preparation (Yada et al., 1986; 
James et al., 1986). The similar observations was also found when polyhistidine 
tag was attached to ovine growth hormone (Khan et al, 1998). 
Differences in ellipticity within the spectral region of 250-300 nm reflects 
modifications in the immediate structural and electronic environment of aromatic 
amino acid residues (Jirgensons, 1970; Creighton, 1991). The mean residue 
ellipticity of modified pepsin is decreased at 260 nm indicating the presence of 
slightly less ordered tertiary structure as compared to native pepsin (Fig 5.9). 
Modified pepsin showed a remarkable increase in binding to the chelating 
matrix. Its binding capacity was 49% higher than that of the native pepsin at pH 8 
(Fig 5.10). The elution profile also shows the high affinity of the modified pepsin 
108 
for Cu '^^ -IDA Sepharose as modified pepsin gets eluted at a higher salt concentration 
than native pepsin (Fig 5.11). While it has been shown that single accessible surface 
histidine may be adequate to retain a protein strongly on metal chelate support 
(Arnold, 1991), attachement of additional histidine residue may increase the affinity 
of the enzyme for the support. Thus Chaga (1994) have coupled histidine residues 
to glycosyl chains of glycoproteins subsequent to their oxidation by periodate. 
Thus it was possible to remarkably increase the affinity of P. chrysogenum glucose 
oxidase for metal ion chelated support and confer affinity to HRP that does not 
bind to metal chelate support in the native form. 
For the purification of F(ab)'2 fragment, IgG was incubated with the modified 
pepsin preparation at pH 4.5 for 24 hours at 37°C (Nisonoff ef al., 1960; Parham, 
1986) and F(ab)'2 was obtained by loading the modified pepsin digest to Cu^ -^
IDA Sepharose (Fig 5.14). The single band in lane a, Fig 5.14 shows that any 
fragmented Fc or intact IgG present in the digested preparation were bound to the 
matrix while F(ab)'2 remained in the unbound fraction. 
Experiments performed to study the cleavage of IgG with modified pepsin 
shows that IgG is best cleaved at pH 3.5 (Fig 5.15). It is also evident from Fig 
5.16 and 5.17 that IgG is cleaved in one hour incubation with modified pepsin at 
40°C. 
Interestingly even the monomeric F(ab) is selectively separated from F(ab)'2 
during the procedure, when F(ab) and F(ab)'2 were mixed and loaded on 
Cu^*-IDA. The supernatant collected after centrifugation of the Cu'^ ^-IDA-
Sepharose revealed the presence of F(ab)'2 only (Fig 5.18 lane a). Possibility of 
the formation of F(ab) monomers exists during treatment of IgG with proteases 
like pepsin (Hale and Biedler, 1994). 
109 
At pH 3.5 there is little binding of Cu-* to the IDA-Sepharose hence there is 
poor binding of modified pepsin to the support (Fig 5.10). At pH 3.5 therefore 
most of the modified pepsin remains in solution and acts actively on IgG. When 
the pH is adjusted to 8.0 most of the Cu^ ^ binds to IDA-Sepharose and in turn 
bind all pepsin. The Cu '^^ -IDA Sepharose also binds any intact IgG, F(ab) fragment 
or Fc fragment containing the histidine rich binding site leaving in solution only 
F(ab)'2 and as shown earlier (Fig 5.14) any F(ab) monomer formed is also likely to 
be removed from the solution leaving only F(ab)'2 (Fig 5.18). 
Significantly the procedure for the preparation of F(ab)'2 could also be 
applied directly to serum. Incubation of the serum with the modified pepsin resulted 
in degradation of majority but not all the proteins. It is evident from the Fig 5.19 
that Cu^*-IDA Sepharose binds nearly all the other proteins present in the digest 
of the serum leaving F(ab)'2 in the supernatant. The high affinity of the support 
for the serum proteins is effective in the complete removal of all the protein other 
than F(ab)'2. High binding affinity of Cu '^^ -IDA Sepharose for albumin was earlier 
reported by Hanson and Kagedal (1981). 
The fragmentation of IgG and purification of F(ab)'2 was also substantiated 
by HPLC. On fragmentation of IgG with modified pepsin and subsequent binding 
of the mixture on Cu^*-IDA Sepharose, a single peak with retention time of 13 
minutes was obtained that corresponded with that of F(ab)'2 (Fig 5.20). The 
chromatogram with the digested but not incubated with Cu '^^ -IDA Sepharose shows 
a small peak at the retention time of 11 minutes which corresponds v/ith the peak 
for native IgG. This sugests that the metal ion support completely binds any intact 
IgG left in the preparation. The chromatogram obtained from size exclusion HPLC 
using the whole antiserum processed similarly also shows a single peak at the 
retention time of 13 minutes (Fig 5.21). 
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In order to make the technique of F(ahy^ formation more simple and 
applicable to small sample volumes, attempts were made to isolate F(ab)'j from 
IgG in a single tube .A diagrammatic representation of single tube incubation 
system was shown in Fig 6.3. CuClj, IDA-Sepharose and modified pepsin were 
taken in sodium acetate buffer pH 3.5 to which was added IgG. After one hour of 
incubation at 40''C adequate NaOH was added to change the pH to 8 and terminate 
the reaction. Single band in PAGE and reducing PAGE confirms that all the proteins 
and the peptides except F(ab)'2 binds to the matrix (Fig 5.22). While the modified 
pepsin is expected to completely bind to the IDA-Sepharose under the conditions. 
The procedure appears to be applicable for the preparation of F(ab)'2 
fragment from IgG derived from various mammalian sources (Fig 5.23). Also the 
F(ab)'2 seems to retain their ability to bind the antigen effectively as observed by 
immunodiffusion (Fig 5.24). 
Figure 6.3 Diagrammatic representation ofthe preparation of F(ab)'2 from IgG 
and its separation from uncleaved IgG, pepsin and Fc fragment 
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7.0 Summarj' 
Recent years have witnessed a remarkable interest in the improvement of 
sensitivities of enzyme based immunoassays for detection and quantification of 
various anaiytes. Immunoassays combine the remarkable specificity of antibodies 
with that of enzymes to catalytically generate a chromogen and can be applied 
virtually to any substance of interest. The first part of the thesis deals with the use 
of a multiple incubation assay with primary antibody and the secondary antibody 
HRP conjugate for enhancement in the sensitivity of the HRP-based immunoassays 
using human serum albumin (HSA) as the model antigen. 
The multiple incubation assay is based on the observation that when a 
polyvalent antibody binds to an antigen immobilized on solid support, all the binding 
sites do not have the opportunity to combine with the antigen for steric reasons 
and some of these remain free. Similarly when the secondary antibody-enzyme 
conjugate is incubated with the nitrocellulose strips bearing antigen with bound 
primary antibody some of the binding sites on the conjugate also remain unoccupied. 
When the strips are again incubated with primary antibody, significant binding of 
the later therefore occurs and the unoccupied sites of the later have the potential 
to bind additional conjugate molecules. Thus "layers" of primary antibody and the 
conjugate can be assembled that contain enzyme conjugate in quantities 
proportional to the concentration of the antigen. Using anti-HSA-IgG and HRP-
anti rabbit-IgG conjugate it was possible to remarkably improve the sensitivity of 
antigen detection on the nitrocellulose strips. The sensitivity of detection increased 
over 100-fold after four incubation cycles with primary antibody and the conjugate 
as compared to that of the standard procedure. While it was possible to further 
increase the sensitivity of detection by increasing the number of incubation cycles, 
the background staining also increased significantly. 
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The sensitivity of detection of HSA by multiple incubation procedure could 
be increased, but only moderately, by replacing the intact primary anti-HSA-IgG 
with the F(ab)'2 fragment derived thereof as well as by crosslinking the antibody 
with glutaraldehyde. The assay appeared suitable for the micro-detection of HSA 
in human serum samples. 
The multiple incubation assay could also be used to demonstrate the 
aggregation of HSA at very small concentrations of the protein. For this purpose 
HSA was subjected to electrophoresis and transferred onto nitrocellulose 
membrane, and the nitrocellulose strips taken through the multiple incubation assays 
prior to staining for HRP activity. While only the sample bearing 560 ng of protein 
exhibited the aggregation when visualized by the standard procedure, aggregation 
was evident even in samples containing 5.6 ng of protein after four incubation 
cycles 
The multiple incubation assay was also useful in increasing the sensitivity of 
HSA by ELISA and unlike the standard procedure with the detection limit of 10 
pg, even 1 pg of HSA could be quantitated conveniently after four incubation 
cycles. 
F(ab)'2 fragments of antibodies are currently of great interests both as 
diagnostic and therapeutic agents, as they retain full binding activity but lack the 
effector functions conferred by the Fc domain. Generally the procedures available 
for the purification of ¥{ab)\ are time consuming, requiring several steps for 
digestion of IgG as well as separation and purification of the fragments. 
Contamination of the F(ab)'2 preparation with the proteolytic enzyme used for the 
cleavage of IgG, F(ab) or Fc poses are quite problematic. Therefore attempts 
have been made to develop a simple procedure for obtaining pure F(ab)', using 
immobilized metal ion affinity chromatography (IMAC). As shown in second part 
of the thesis, pepsin was chemically modified for the purpose by attaching histidine 
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to the lysine residue of the enzyme. The modification resuhed in 49% enhancement 
in the binding affinity of the modified pepsin for Cu^*-IDA Sepharose. Kinetic and 
spectral parameters studied for porcine pepsin after modification showed no 
significant change in the K^^ and V^^ ^ values. UV, fluorescence and CD spectra 
also showed that there is no major change in the structure of modified pepsin. 
Investigations of the dependence of IgG cleavage on temperature, pH, 
incubation time with modified pepsin were studied and it was found that IgG 
(Img/ml) was best cleaved at pH 3.5 in one hour incubation time at 40°C. 
The modified pepsin was effective in converting IgG to F(ab)'2. When the 
pepsin IgG digest was allowed to bind to Cu^'^-IDA-Sepharose at pH 8, the modified 
pepsin gets bound to the matrix along with any F(ab) and Fc fragment present in 
the digest leaving F(ab)'2 in the solution. Purity of F(ab)'2 obtained thus was 
confirmed by size exclusion HPLC and showed the presence of a single peak with 
the retention time of 13 minutes that corresponded with that of F(ab)'2. The 
procedure was also effective in purification of F(ab)'2 directly from the serum 
without the need for IgG purification. 
The complete procedure of F(ab)'2 purification was achieved in a single 
tube incubation system to make it more convenient and effective for small sample 
volumes. For this purpose IgG was transfered to small tubes containing CuCl^, 
IDA-Sepharose and modified pepsin in sodium acetate buffer pH 3.5 and incubated 
at 40°C for one hour. Subsequently the pH of the reaction mixture was adjusted to 
8 by adding NaOH solution. At pH 8 the modified pepsin and other major 
polypeptides were bound to the support, and electrophoresis of the unbound 
fraction showed only a single band in SDS-PAGE corresponding to the of F(ab)',. 
The procedure was useful in the preparation of F(ab)'2 from the IgG of 
various mammalian species. The F(ab)', prepared thus also retained their ability to 
combine with the antigen as revealed by immunodiffusion. 
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